<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
<link rel="stylesheet" href="https://www.w3schools.com/icons/fontawesome5_icons_code.asp">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
<link rel='stylesheet' href='https://use.fontawesome.com/releases/v5.7.0/css/all.css' integrity='sha384-lZN37f5QGtY3VHgisS14W3ExzMWZxybE1SJSEsQp9S+oqd12jhcu+A56Ebc1zFSJ' crossorigin='anonymous'>
<!-- HTML5 and CSS code adapted from W3Schools -->
<style>
* {
  box-sizing: border-box;
}

#myInput {
  background-image: url('/css/searchicon.png');
  background-position: 10px 10px;
  background-repeat: no-repeat;
  width: 100%;
  font-size: 16px;
  padding: 12px 20px 12px 40px;
  border: 1px solid #ddd;
  margin-bottom: 12px;
  font-family: Garamond, Baskerville, "Baskerville Old Face";
}

#myTable {
  border-collapse: collapse;
  width: 100%;
  border: 1px solid #ddd;
  font-size: 18px;
}

#myTable th, #myTable td {
  font-family: Garamond, Baskerville, "Baskerville Old Face";
  text-align: center;
  padding: 12px;
}

#myTable tr {
  border-bottom: 1px solid #ddd;
}

#myTable tr.header, #myTable tr:hover {
  background-color: #006400;
  background-color: #006400;
  color: white;
}
h2 {
    font-family: Garamond, Baskerville, "Baskerville Old Face";
    font-size: 30px;
    text-align: center;
}

body {background-color: white;
  font-family: Garamond, Baskerville, "Baskerville Old Face";
  font-size: 20px;
  color: black;
}

.w3-bar .w3-button {
  padding: 16px;
}

.dropbtn {
  background-color: grey;
  color: white;
  padding: 16px;
  font-size: 20px;
  border: none;
}

.dropdown {
  position: relative;
  display: inline-block;
}

.dropdown-content {
  display: none;
  position: absolute;
  background-color: #f1f1f1;
  min-width: 280px;
  box-shadow: 0px 8px 16px 0px rgba(0,0,0,0.2);
  z-index: 1;
}

.dropdown-content a {
  color: black;
  padding: 12px 16px;
  text-decoration: none;
  display: block;
}

.dropdown-content a:hover {background-color: white;}

.dropdown:hover .dropdown-content {display: block;}

.dropdown:hover .dropbtn {background-color: darkgreen;}

.section {
  padding: 10px;
}

.column1of2 {
  width: 22%;
  float: left;
  padding-top: 60px;
}

.column2of2 {
  width: 78%;
  float: right;
  padding-top: 60px;
}

.footer {
  background-color: rgba(225, 225, 225, 0.75);
  color: black;
  text-align: center;
  font-size: 12px;
  padding: 15px;
}
table, th, td {
  border: 1px solid black;
  border-collapse: collapse;
  font-size: 16px;
}

}
</style>
</head>
<body>
<div class="w3-top">
  <div class="w3-bar w3-white w3-card" id="myNavbar">
    <a href="index.html" class="w3-bar-item w3-button w3-wide">AgingHallmarkDB</a>
    <div class="w3-right w3-hide-small">
      <a href="index.html" class="w3-bar-item w3-button">Main</a>
      <a href="about.html" class="w3-bar-item w3-button">About</a>
      <a href="manual_curation_GI.html" class="w3-bar-item w3-button">Curation</a>
      <a href="literature_GI.html" class="w3-bar-item w3-button">Literature</a>
    </div>
    <a href="javascript:void(0)" class="w3-bar-item w3-button w3-right w3-hide-large w3-hide-medium" onclick="w3_open()">
      <i class="fa fa-bars"></i>
    </a>
  </div>
</div>

<nav class="w3-sidebar w3-bar-block w3-black w3-card w3-animate-left w3-hide-medium w3-hide-large" style="display:none" id="mySidebar">
  <a href="javascript:void(0)" onclick="w3_close()" class="w3-bar-item w3-button w3-large w3-padding-16">Close Ã—</a>
  <a href="index.html" onclick="w3_close()" class="w3-bar-item w3-button">Main</a>
  <a href="about.html" onclick="w3_close()" class="w3-bar-item w3-button">About</a>
  <a href="manual_curation_GI.html" onclick="w3_close()" class="w3-bar-item w3-button">Curation</a>
  <a href="literature_GI.html" onclick="w3_close()" class="w3-bar-item w3-button">Literature</a>
</nav>
<div class="section">
<div class="column1of2">
<div class="dropdown">
  <button class="dropbtn">Select Aging Hallmark</button>
  <div class="dropdown-content">
    <a href="literature_GI.html">Genomic Instability</a>
    <a href="literature_TA.html">Telomere Attrition</a>
    <a href="literature_EA.html">Epigenetic Alterations</a>
    <a href="literature_LOP.html">Loss of Proteostasis</a>
    <a href="literature_DNS.html">Deregulated Nutrient Sensing</a>
    <a href="literature_MD.html">Mitochondrial Dysfunction</a>
    <a href="literature_CS.html">Cellular Senescence</a>
    <a href="literature_SCE.html">Stem Cell Exhaustion</a>
    <a href="literature_AIC.html">Altered Intercellular Communication</a>
  </div>
</div>
</div>
<div class="column2of2">
<h2><b>Telomere Attrition</h2></b>
<ul><li>The table below contains sentences from PubMed articles, which describe the contribution of telomere attrition in the development, or disordered physiology of, a disease.</li>
  <li>The sentences are derived from predictions after applying a supervised machine learning approach.</li>
  <li>The columns represent the matched concept from the UMLS Metathesaurus, the matched aging hallmark, the sentence and the PubMed identifier.</li>
  <li>There are hyperlinks to the associated PubMed article.</li>
  <li>To view sentences for different aging hallmarks, navigate from the drop-down list on the left.</li>
</ul>
<input type="text" id="myInput" onkeyup="myFunction()" placeholder="Search for names.." title="Type in a name">
<table id="myTable" border="3">
  <tr class="header">
    <th style="width:15%;">Matched Disease Name</th>
    <th style="width:15%;">Matched Aging Hallmark</th>
    <th style="width:50%;">Sentence</th>
    <th style="width:10%;">PMID</th>
  </tr>
<tr><td>Myeloid-Lymphoid Leukemia Protein</td><td>Telomere Attrition</td><td>The average telomere length was 4.8 and 4.7 kb in myeloid and lymphoid leukemia, respectively, while the telomere length in peripheral blood mononuclear cells obtained from the same patients during complete remission was 8.5 and 7.9 kb, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/7883960'>7883960</td>
<tr><td>Neoplasms, Carcinoma of lung</td><td>Telomere Attrition</td><td>We investigated the relationship between telomere length and various characteristics of tumor cells in 46 lung cancer specimens (40 primary lesions and six metastatic lesions).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/8081703'>8081703</td>
<tr><td>FAM126A gene</td><td>Telomere Attrition</td><td>All the HCC samples examined demonstrated shorter telomere length than the corresponding non-cancerous liver tissues, the respective average values being 5.4 kbp and 8.8 kbp (P < 0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/8641975'>8641975</td>
<tr><td>Liver diseases</td><td>Telomere Attrition</td><td>Telomere length in human liver diseases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/8938628'>8938628</td>
<tr><td>Chronic liver disease, FAM126A gene, Liver carcinoma, Hepatocarcinogenesis</td><td>Telomere Attrition</td><td>To determine the role of telomere-mediated gene stability in hepatocarcinogenesis, we examined the telomere length of human liver with or without chronic liver diseases and hepatocellular carcinomas (HCC).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/8938628'>8938628</td>
<tr><td>Hepatocarcinogenesis</td><td>Telomere Attrition</td><td>Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9062581'>9062581</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>The maintenance of telomere length is assumed to be an obligatory step in the progression and immortalization of most human tumor cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9062581'>9062581</td>
<tr><td>MYELODYSPLASTIC SYNDROME, Fanconi Anemia, PAFAH1B1 wt Allele, Paroxysmal nocturnal hemoglobinuria, Hemoglobinuria, CTCAE 3.0</td><td>Telomere Attrition</td><td>To investigate whether accelerated senescence of hematopoietic stem cells might underlie the pathophysiology of myelodysplasia (MDS) or paroxysmal nocturnal hemoglobinuria (PNH) occurring as a late complication of AA, we studied mean telomere length (TRF) in peripheral blood leukocytes from 79 patients with AA, Fanconi anemia, or PNH in comparison with normal controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9572992'>9572992</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>In three astrocytic tumors, concurrence of telomere shortening and telomerase reactivation was observed at recurrence; in these cases, tumors progressed to a higher grade.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9605755'>9605755</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Telomerase activity and alterations in telomere length in human brain tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9605755'>9605755</td>
<tr><td>Leukemia, Myelocytic, Acute, Acute lymphocytic leukemia</td><td>Telomere Attrition</td><td>There was no relationship between peak telomere length and telomerase activity in both acute lymphoid leukemia and AML patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/9815729'>9815729</td>
<tr><td>CD55 gene</td><td>Telomere Attrition</td><td>Concomitant analyses of TC and average telomere length revealed that both values were significantly correlated (r =.45; P =.009).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10421648'>10421648</td>
<tr><td>Chronic myeloproliferative disorder</td><td>Telomere Attrition</td><td>We studied telomerase regulation and telomere length in hematopoietic progenitor cells from peripheral blood and bone marrow from patients with acute and chronic leukemia and myeloproliferative diseases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10676644'>10676644</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10706851'>10706851</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>To circumvent this problem, we compared the telomere length in peripheral blood or bone marrow cells with purified normal (Ph(-)) T lymphocytes from the same CML patient using fluorescence in situ hybridization and flow cytometry.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10706851'>10706851</td>
<tr><td>Muscular Dystrophy</td><td>Telomere Attrition</td><td>Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10714586'>10714586</td>
<tr><td>dystrophic</td><td>Telomere Attrition</td><td>In this study we have used the telomere length to quantify the intensity of the muscle cell turnover in biopsies from dystrophic patients of different ages.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10714586'>10714586</td>
<tr><td>Allogeneic Hematopoietic Stem Cell Transplantation</td><td>Telomere Attrition</td><td>Telomere length of peripheral blood mononuclear cells (PBMCs) from 23 autologous HSCT patients ranging from 4 to 61 years old, and 46 allogeneic HSCT recipients from 6 to 52 years old were studied to confirm whether excessive shortening of telomeres is associated with HSCT.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10723589'>10723589</td>
<tr><td>HIV Infections</td><td>Telomere Attrition</td><td>Telomere analyses in this study show a clear (P < 0.0001) inverse relationship between telomere length and progression of immunosuppression, with HIV infection resulting in a five-fold or greater acceleration of aging of the circulating PBMC component of the immune system.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10839584'>10839584</td>
<tr><td>Atherosclerosis</td><td>Telomere Attrition</td><td>In this work we explored the rate of telomere attrition as a function of age and atherosclerosis in cells of the human abdominal aorta.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10998467'>10998467</td>
<tr><td>atherosclerotic</td><td>Telomere Attrition</td><td>Telomere length was then correlated with age and atherosclerotic grade.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10998467'>10998467</td>
<tr><td>atherosclerotic</td><td>Telomere Attrition</td><td>In addition, telomere length was negatively correlated with atherosclerotic grade.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/10998467'>10998467</td>
<tr><td>Psoriasis, Dermatitis, Atopic</td><td>Telomere Attrition</td><td>The telomere length was significantly reduced in all T cell subsets from both atopic dermatitis and psoriasis patients compared with normal individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11035119'>11035119</td>
<tr><td>Ependymoma of brain, Glioma</td><td>Telomere Attrition</td><td>To further investigate the role of telomere and telomerase regulation in the pathogenesis of non-astrocytic gliomas, we examined the telomere length and the mRNA expression of telomerase reverse transcriptase gene (hTERT) and telomerase-associated protein (hTEP) in a series of 27 oligodendroglial and 18 ependymal tumors in this study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11087056'>11087056</td>
<tr><td>Neoplasms, NCI CTEP SDC Oligodendroglial Tumors Sub-Category Terminology</td><td>Telomere Attrition</td><td>No statistical difference was found between the mean telomere length in telomerase-positive and telomerase-negative tumors (11.5 kb vs 13.1 kb; p = 0.424), although a slightly shorter length was observed in telomerase-positive oligodendroglial tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11087056'>11087056</td>
<tr><td>Dementia, Vascular</td><td>Telomere Attrition</td><td>Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11092534'>11092534</td>
<tr><td>Dementia, Vascular</td><td>Telomere Attrition</td><td>Telomere length may be an independent predictor for the risk of vascular dementia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11092534'>11092534</td>
<tr><td>Pancytopenia</td><td>Telomere Attrition</td><td>However, surprisingly, telomere length in granulocytes from AA patients who had recovered after immunosuppressive therapy did not differ significantly from controls, whereas untreated patients and nonresponders with persistent severe pancytopenia showed marked and significant telomere shortening.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11159514'>11159514</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Telomere length in leukocyte subpopulations of patients with aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11159514'>11159514</td>
<tr><td>Paroxysmal nocturnal hemoglobinuria, Aplastic Anemia, Bone Marrow Failure Disorders</td><td>Telomere Attrition</td><td>To study the turnover of stem cells in patients with bone marrow failure syndromes, the telomere length in peripheral blood granulocytes and lymphocytes from patients with aplastic anemia (AA, n = 56) and hemolytic paroxysmal nocturnal hemoglobinuria (n = 6) was analyzed relative to age-matched controls by means of fluorescence in situ hybridization and flow cytometry.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11159514'>11159514</td>
<tr><td>BCR protein, human, Leukemia, Myelocytic, Acute, Acute lymphocytic leukemia</td><td>Telomere Attrition</td><td>TRF1 expression, which is believed to control telomere length, was significantly elevated in patients with acute lymphoblastic leukemia (ALL) (P=0.0232) compared to those in acute myeloid leukemia (AML); TRF1 expression tended to be higher in patients without telomere shortening (P=0.077) and in those with hTERT expression (P=0.055).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11179492'>11179492</td>
<tr><td>Acute leukemia</td><td>Telomere Attrition</td><td>We studied the possible correlation among telomere length, telomerase (a ribonuclear protein that synthesizes the telemeres de novo) activity, hTERT (a catalytic subunit of telomerase) expression, and TRF1 and TRF2 (telomere DNA binding proteins) expression in human acute leukemia cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11179492'>11179492</td>
<tr><td>Acute leukemia</td><td>Telomere Attrition</td><td>Although the precise regulation mechanism of telomere length is still uncertain, these results may suggest that regulation of telomere length is partially associated with TRF1 expression, whereas dysfunction of TRF1 expression may be speculated in a subset of acute leukemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11179492'>11179492</td>
<tr><td>Dyskeratosis Congenita, X-linked inheritance</td><td>Telomere Attrition</td><td>Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11259155'>11259155</td>
<tr><td>Leukopenia</td><td>Telomere Attrition</td><td>Positive correlation was observed between the extent of telomere shortening, the severity of neutropenia (P = 0.05) and the degree of mean corpuscular volume elevation (P = 0.005) at the time of the study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11298602'>11298602</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Telomere length changes in patients with aplastic anaemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11298602'>11298602</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>To investigate telomere changes in patients with aplastic anaemia (AA) and clinical factors influencing the telomere dynamics, telomere length (TL) was measured in peripheral blood mononuclear cells using Southern blot analysis of 42 patients with AA and 39 healthy normal controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11298602'>11298602</td>
<tr><td>Encephalitis, St. Louis, Lupus Erythematosus</td><td>Telomere Attrition</td><td>To evaluate whether the immune system of systemic lupus erythematosus (SLE) patients shows features of premature aging, we compared telomere length and proliferative potential of SLE peripheral blood mononuclear cells (PBMC) (N = 90) to those of controls (N = 64).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11318593'>11318593</td>
<tr><td>Neoplasms, Intracranial</td><td>Telomere Attrition</td><td>Differential telomerase expression and telomere length in primary intracranial tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11512366'>11512366</td>
<tr><td>Neoplasms, Intracranial</td><td>Telomere Attrition</td><td>The authors examined telomerase activity and telomere length in intracranial tumors to determine the clinicopathological behavior of primary intracranial tumors with respect to telomerase expression and alteration of telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11512366'>11512366</td>
<tr><td>Neoplasms, Neuroepithelial</td><td>Telomere Attrition</td><td>Elongation of telomere length was detected in 12.6% (11/87) of the cases and 23.5% (12/51) in neuroepithelial tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11512366'>11512366</td>
<tr><td>Neoplasms, Neuroepithelial, Meningioma</td><td>Telomere Attrition</td><td>Telomere length was reduced in the majority, (75%, 3/4) of malignant or atypical meningiomas with detectable telomerase activity, but only 45% (9/20) of the neuroepithelial tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11512366'>11512366</td>
<tr><td>Neoplasms, Behavior</td><td>Telomere Attrition</td><td>Telomere length elongation also indicates a high potential for malignant behavior in these tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11512366'>11512366</td>
<tr><td>Malignant Neoplasms</td><td>Telomere Attrition</td><td>Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11675499'>11675499</td>
<tr><td>Aneuploidy</td><td>Telomere Attrition</td><td>Aneuploidy and telomere attrition might thus play a role in the aging of the human vasculature.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11730807'>11730807</td>
<tr><td>Aneuploidy</td><td>Telomere Attrition</td><td>Age dependent aneuploidy and telomere length of the human vascular endothelium.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11730807'>11730807</td>
<tr><td>Ataxia Telangiectasia Mutated Proteins</td><td>Telomere Attrition</td><td>Cells derived from patients with the human genetic disorder ataxia-telangiectasia (A-T) display many abnormalities, including telomere shortening, premature senescence, and defects in the activation of S phase and G(2)/M checkpoints in response to double-strand DNA breaks induced by ionizing radiation.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11744712'>11744712</td>
<tr><td>Premature aging syndrome, Turner Syndrome</td><td>Telomere Attrition</td><td>In conclusion, our data suggest that Ullrich-Turner syndrome is not associated with excessive telomere loss, at least when studied in peripheral blood leucocytes, and thus quite different from other premature ageing syndromes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11781707'>11781707</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Telomere length was determined in each tumor sample, using the terminal restriction fragments (TRF) technique.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/11948462'>11948462</td>
<tr><td>Liver Cirrhosis</td><td>Telomere Attrition</td><td>This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12087054'>12087054</td>
<tr><td>Cholesteatoma, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>Despite the differences in telomerase activity, the telomere length was similar in cholesteatoma (mean length 7.43 kb) and in squamous cell carcinoma (mean length 7.99 kb; difference not significant, p = 0.1364).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12218637'>12218637</td>
<tr><td>Malignant Head and Neck Neoplasm</td><td>Telomere Attrition</td><td>Clinical usefulness of telomerase activation and telomere length in head and neck cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12454944'>12454944</td>
<tr><td>Neoplasms, Malignant Head and Neck Neoplasm</td><td>Telomere Attrition</td><td>Telomerase activation and telomere length alterations were studied in tumor and adjacent normal tissues in 110 patients with head and neck cancer and 40 patients with precancerous/benign conditions.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12454944'>12454944</td>
<tr><td>Malignant Head and Neck Neoplasm</td><td>Telomere Attrition</td><td>Our results demonstrate the significant clinical usefulness of telomerase activation and telomere length for head and neck cancer patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12454944'>12454944</td>
<tr><td>Myeloid Leukemia, Chronic, DPM1 gene</td><td>Telomere Attrition</td><td>However, there was no statistical difference in telomere length in T lymphocytes between MPD patients and normal individuals (vs CML, p = 0.35; vs other MPDs, p = 0.85).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12482501'>12482501</td>
<tr><td>Neoplasms, BCR protein, human, Acute lymphocytic leukemia</td><td>Telomere Attrition</td><td>We found that mononuclear cells (MNC) and granulocytes of children with standard-risk acute lymphoblastic leukemia (ALL) suffered minimal telomere shortening throughout therapy (less than 1 kbp; average follow-up, 20 months), while those of children with solid tumors showed greater and more heterogenous telomere attrition (0.5-2.8 kbp, average follow-up, 9 months).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12592340'>12592340</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Accelerated telomere shortening is seen with replicative stress, such as during administration of serial chemotherapy cycles for the treatment of childhood cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12592340'>12592340</td>
<tr><td>Primary malignant neoplasm, Malignant Neoplasms</td><td>Telomere Attrition</td><td>To define the long-term consequences of pediatric cancer treatment on hematopoietic cell telomere length, we undertook a prospective 4-year follow-up study of a 61-patient cohort of pediatric malignancies in a community-based setting.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12592340'>12592340</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>In addition, we evaluated the role of telomerase, the enzyme commonly up-regulated in pediatric leukemic and solid tumor cells for telomere length maintenance, as a disease marker.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12592340'>12592340</td>
<tr><td>Neuroblastoma</td><td>Telomere Attrition</td><td>At 1 year the survival rate in patients with TA levels lower than 25% of neuroblastoma control and TL greater than 5.5 kbp was 82%, whereas in patients with higher TA and shorter TL the survival rate was 63% (P =.004).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12609839'>12609839</td>
<tr><td>Aplastic Anemia, SAA1 gene</td><td>Telomere Attrition</td><td>In studying 71 FA patients, a correlation was found between severe aplastic anaemia (SAA) and the individual annual telomere-shortening rate (IATSR) in peripheral blood mononuclear cells (P < 10(-3)).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12614219'>12614219</td>
<tr><td>Coronary heart disease</td><td>Telomere Attrition</td><td>The results demonstrated that HC and/or DM patients with coronary diseases have significantly shorter telomere length than healthy controls (p = 0.0014).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12636233'>12636233</td>
<tr><td>PAFAH1B1 wt Allele, Chromosome Aberrations</td><td>Telomere Attrition</td><td>Metaphases from most MDS patients showed homogeneous telomere shortening, irrespective of the presence of cytogenetic abnormality.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12684424'>12684424</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>In contrast, we found no linear correlation between TRF length and telomere fluorescence signals in MDS, and most MDS patients showed weak telomere fluorescence signals, corresponding to short telomeres, with a narrow range compared with normal subjects.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12684424'>12684424</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>We measured telomere length in samples from 13 MDS patients and 8 healthy volunteers, based on telomere signals of individual chromosomes, using digital images of metaphases after quantitative fluorescence in situ hybridization (Q-FISH) with peptide nucleic acid probes and compared the results with results obtained with the standard method of determining terminal restriction fragment (TRF) length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12684424'>12684424</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>Therefore, analysis of telomere distribution as well as average telomere length detected by Q-FISH might be useful to clarify the telomere dynamics of MDS cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12684424'>12684424</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>In previous studies, we described substantial and disease stage-specific telomere shortening in peripheral blood (PB) leukocytes from patients with chronic myeloid leukemia (CML).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12799279'>12799279</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12799279'>12799279</td>
<tr><td>selenium</td><td>Telomere Attrition</td><td>Telomere length in samples from start of treatment up to day 144 was significantly shorter (mean +/- SE; -1.5 +/- 0.3 kMESF) compared to samples from patients treated for more than 144 days (-0.8 +/- 0.3 kMESF, p = 0.035).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12799279'>12799279</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>In conclusion, the increase in telomere length under treatment with imatinib reflects a shift from Ph+ to Ph- cells in the PB of patients with CML.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12799279'>12799279</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>When subjects were categorized into telomere length quartiles defined by the distribution in control subjects, the following inverse relationship between telomere length and cancer risk was observed: adjusted odds ratios [ORs] for decreasing quartiles = 0.84 (95% CI = 0.36 to 1.97), 1.77 (95% CI = 0.72 to 4.36), and 5.11 (95% CI = 1.90 to 13.77).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12928346'>12928346</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12945717'>12945717</td>
<tr><td>Encephalitis, St. Louis, Lupus Erythematosus</td><td>Telomere Attrition</td><td>We evaluated the clinical significance of the telomerase activity and telomere length of peripheral blood mononuclear cells (PBMC) in systemic lupus erythematosus (SLE).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12945717'>12945717</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>The telomere length of PBMC in younger SLE patients tended to be shorter than that in the controls, but no difference was observed in older patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12945717'>12945717</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>The correlation coefficient between the telomerase activity and telomere length of PBMC in SLE patients was not significant.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12945717'>12945717</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>Abnormalities in the telomerase activity and telomere length observed in SLE patients are considered to be important findings for evaluation of the pathology of SLE.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/12945717'>12945717</td>
<tr><td>Orosomucoid</td><td>Telomere Attrition</td><td>These results indicate that patients with AgP do not have excessive telomere loss and thus do not support the notion of the occurrence of a generalized premature cellular aging in patients with AgP.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15025219'>15025219</td>
<tr><td>Thanatophoric Dysplasia</td><td>Telomere Attrition</td><td>We speculate that short telomere length and low telomerase activity may be important for chondrocyte differentiation in rhizomeric shortening of the limbs in thanatophoric dysplasia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15116319'>15116319</td>
<tr><td>Primary malignant neoplasm, physiopathological</td><td>Telomere Attrition</td><td>Dysfunctional telomeres can cause genetic instability in vitro and an increased cancer incidence in telomerase knock out mouse models.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15161685'>15161685</td>
<tr><td>Therapy-Related Acute Myeloid Leukemia</td><td>Telomere Attrition</td><td>Moreover, accelerated telomere shortening may be induced by replicative stress or oxidative damage, leading to genomic instability, and inactivating polymorphisms of the gene encoding NADPH-quinone oxidoreductase (NQO1) are more frequently observed in patients with t-AML.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15198733'>15198733</td>
<tr><td>Therapy-Related Acute Myeloid Leukemia</td><td>Telomere Attrition</td><td>Patients with the NQO1-187Ser polymorphism have an increased risk of developing both clonal haemopoiesis and telomere shortening, which may partly explain the predisposition to t-AML in NQO1-187Ser null individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15198733'>15198733</td>
<tr><td>MYELODYSPLASTIC SYNDROME, PAFAH1B1 wt Allele, Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15289012'>15289012</td>
<tr><td>MYELODYSPLASTIC SYNDROME, Childhood Leukemia, Leukemia, Myelocytic, Acute, PAFAH1B1 wt Allele, Primary</td><td>Telomere Attrition</td><td>Telomere length was evaluated by terminal repeat fragment method (TRF) in 50 patients with myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) arising from MDS and in 21 patients with untreated primary AML to ascertain, whether telomere erosion was associated with progression of MDS towards overt leukemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15289012'>15289012</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>Chromosomal aberrations were present in 32% MDS patients with more eroded telomeres (P=0.022), nevertheless a difference between mean TRF in the subgroups with normal and abnormal karyotype diminished during progression of MDS.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15289012'>15289012</td>
<tr><td>Down Syndrome</td><td>Telomere Attrition</td><td>Determination of telomere length by flow-fluorescence in situ hybridization in Downs syndrome patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15573694'>15573694</td>
<tr><td>Down Syndrome, "Alzheimers Disease", Werner Syndrome</td><td>Telomere Attrition</td><td>Both Southern blot analysis and Q-FISH have specific limitations and are time-consuming, whereas flow-FISH needed relatively few cells (1.5-2.5 x 106) and could be completed in 24-48 h. The method can be used to rapidly determine telomere length in subsets of nucleated blood cells from patients with age-related diseases such as Downs syndrome, Alzheimers disease and Werner syndrome.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15573694'>15573694</td>
<tr><td>Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>The expression of TRF1 is lower in ANLL cells, which indicates TRF1 may have some effect on telomerase activity by regulating telomere length in ANLL cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15586404'>15586404</td>
<tr><td>Werner Syndrome</td><td>Telomere Attrition</td><td>Cells from Werner syndrome patients are characterized by slow growth rates, premature senescence, accelerated telomere shortening rates, and genome instability.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15591207'>15591207</td>
<tr><td>Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>Age-adjusted telomere length in AML patients was significantly reduced as compared to in matched controls, consisting of peripheral blood granulocytes from healthy individuals (0-90 years) (median: -2.5 TFU; p<0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15749662'>15749662</td>
<tr><td>Paroxysmal nocturnal hemoglobinuria</td><td>Telomere Attrition</td><td>Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15811960'>15811960</td>
<tr><td>selenium</td><td>Telomere Attrition</td><td>We found significantly shortened telomeres in GPI- granulocytes (mean +/- SE: 6.26 +/- 0.27 telomere fluorescence units [TFU]), both compared with their GPI+ counterparts (6.88 +/- 0.38 TFU; P = .03) as well as with age-matched healthy individuals (7.73 +/- 0.23 TFU; P < .001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15811960'>15811960</td>
<tr><td>Bone marrow hypocellularity</td><td>Telomere Attrition</td><td>Telomere length has been linked to disease stage and degree of (pan-)cytopenia in patients with bone marrow failure syndromes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15811960'>15811960</td>
<tr><td>Paroxysmal nocturnal hemoglobinuria</td><td>Telomere Attrition</td><td>The aim of the current study was to analyze the impact of replicative stress on telomere length in residual glycosylphosphatidylinositol-positive (GPI+) versus GPI- hematopoiesis in patients with paroxysmal nocturnal hemoglobinuria (PNH).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/15811960'>15811960</td>
<tr><td>Thrombocytosis, Polycythemia Vera</td><td>Telomere Attrition</td><td>Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16042688'>16042688</td>
<tr><td>Thrombocytosis, Polycythemia Vera</td><td>Telomere Attrition</td><td>Summary The purpose of this study was to evaluate telomere length in peripheral blood granulocytes and mononuclear cells collected from 22 women with polycythaemia vera (PV) and essential thrombocythaemia (ET).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16042688'>16042688</td>
<tr><td>Inflammation</td><td>Telomere Attrition</td><td>Both are states of heightened oxidative stress, which increases the rate of telomere erosion per replication, and inflammation, which enhances white blood cell turnover.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16112303'>16112303</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16142233'>16142233</td>
<tr><td>Ulcerative Colitis</td><td>Telomere Attrition</td><td>The aim of this study is to investigate whether the impaired function of rectal fibroblasts in UC is due to accelerated telomere shortening, oxidative stress and premature senescence.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16394794'>16394794</td>
<tr><td>Steatohepatitis</td><td>Telomere Attrition</td><td>Greater insulin resistance can result in more severe hepatic steatosis among group B patients, leading to an overproduction of reactive oxygen species, which may accelerate telomere erosion.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16420506'>16420506</td>
<tr><td>Non-alcoholic Fatty Liver Disease</td><td>Telomere Attrition</td><td>Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16420506'>16420506</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Telomere length in the colon declines with age: a relation to colorectal cancer?</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16537718'>16537718</td>
<tr><td>Adenoma</td><td>Telomere Attrition</td><td>Telomere length in larger adenoma lesions (>2 cm) was significantly shorter than in normal adjacent (P = 0.004) or normal distant (P = 0.05) tissue from the same individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16537718'>16537718</td>
<tr><td>Mortality, Premature</td><td>Telomere Attrition</td><td>On one hand, critically short telomeres trigger loss of cell viability and premature death in mice deficient for telomerase activity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16582635'>16582635</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>These mice show short telomeres in the presence of telomerase activity, leading to premature aging and increased cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16582635'>16582635</td>
<tr><td>Neoplasms, Acute Promyelocytic Leukemia</td><td>Telomere Attrition</td><td>Tumor samples were analyzed with respect to telomerase activity, telomere length, and ALT-associated promyelocytic leukemia nuclear bodies to determine their TMM.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16818615'>16818615</td>
<tr><td>Cervical Intraepithelial Neoplasia</td><td>Telomere Attrition</td><td>Early-stage cervical intraepithelial neoplasias (CINs), especially CIN2, had significantly shorter telomeres than corresponding normal squamous epithelia (p = 0.019), together with increased rates of chromosomal arm loss/gain (p < 0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16909412'>16909412</td>
<tr><td>Endometrial Hyperplasia, Malignant neoplasm of endometrium</td><td>Telomere Attrition</td><td>In contrast, there was no significant difference between the telomere length of normal endometrium and of endometrial hyperplasia and endometrial cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/16909412'>16909412</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent, atherosclerotic</td><td>Telomere Attrition</td><td>Among subjects with Type 2 diabetes, those with atherosclerotic plaques had greater shortening of telomere length compared to those without plaques.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17222848'>17222848</td>
<tr><td>Osteoporosis</td><td>Telomere Attrition</td><td>Longer telomeres were associated with reduced the risk of clinical OP at two or more sites (odds ratio = 0.594 95% CI 0.42-0.84 p < 0.003) and in women over the age of 50, clinical osteoporosis was associated with 117 bp shorter telomere length (p < 0.02) equivalent to 5.2 years of telomeric aging.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17347788'>17347788</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>There was a significant correlation between telomere length and tumor size, with telomeres being shorter with increasing tumor size (p = 0.049), and between telomere length and PCNA-positive cell rate, with telomere shortening with increased positive cell rate (p = 0.017).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17352261'>17352261</td>
<tr><td>Extra-abdominal fibromatosis</td><td>Telomere Attrition</td><td>Telomere length and telomerase activity in extra-abdominal desmoid tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17352261'>17352261</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Telomere length increased with recurrence, but telomerase activity decreased, and rate of PCNA-positive cells became lower, whenever the tumors were recurrent.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17352261'>17352261</td>
<tr><td>Neoplasms, Aggressive behavior</td><td>Telomere Attrition</td><td>Decreasing telomere length correlated with tumor size, probably due to increased duration of proliferation in the tumor, and tumor aggressiveness.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17352261'>17352261</td>
<tr><td>Liver carcinoma</td><td>Telomere Attrition</td><td>These data indicate that LCC and SCC represent clonal expansions of hepatocytes with shortened telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17393506'>17393506</td>
<tr><td>Liver Cirrhosis, FAM126A gene, Liver carcinoma</td><td>Telomere Attrition</td><td>The study shows a decrease in telomere length in nondysplastic cirrhotic liver compared with normal liver and a further significant shortening of telomeres in LCC, SCC, and HCC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17393506'>17393506</td>
<tr><td>Malignant neoplasm of urinary bladder</td><td>Telomere Attrition</td><td>Using quantitative real-time PCR, we measured relative telomere length in bladder cancer cases and healthy controls and evaluated the association between telomere length, cigarette smoking, and bladder cancer risk in a case-control study nested within the Health Professionals Follow-up Study and a case-control study nested within the Nurses Health Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17416776'>17416776</td>
<tr><td>LIPC protein, human, Chromosome Aberrations</td><td>Telomere Attrition</td><td>Compared with controls, patients from the prospective HL cohort, before any treatment, showed age-independent shorter telomeres (mean, 8.3 vs. 11.7 kb in healthy donors; <6 kb in 18% in HL patients), increased spontaneous chromosomal abnormalities, and increased in vitro radiation sensitivity (p < 10(-4) each).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17418962'>17418962</td>
<tr><td>Disease</td><td>Telomere Attrition</td><td>SLE disease activity (SLEDAI) contributed remarkably to the accelerated telomere erosion, at least in PMN.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Lupus Erythematosus, Lupus Vulgaris</td><td>Telomere Attrition</td><td>Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis, Immature</td><td>Telomere Attrition</td><td>These data suggested that MNC and PMN from patients with SLE displayed premature and accelerated telomere shortening that SLE is an independent factor for it.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>We measured the telomere length of MNC and PMN in 60 SLE patients and 26 sex-, race- and age-matched healthy volunteers by Southern blotting with chemiluminescence method.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>We found the telomere length of MNC and PMN shortened with age in different degrees in both SLE and control groups.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>Compared to the control group, the telomere length was shortened in both SLE-MNC (6.08 kb in SLE versus 6.71 kb in control, P = 0.0008) and PMN (6.24 kb in SLE versus 6.75 kb in control, P = 0.0025).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis</td><td>Telomere Attrition</td><td>The average reduction in telomere length in SLE patients was equivalent to a premature senescence of 16.5 years in MNC and 13.4 years in PMN.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>Encephalitis, St. Louis, Lymphopenia, White blood cell count decreased</td><td>Telomere Attrition</td><td>Moreover, the telomere length of MNC was significantly shorter than PMN in the same SLE patients with leukopenia and lymphopenia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17439933'>17439933</td>
<tr><td>BONE MARROW FAILURE SYNDROME 1, Dyskeratosis Congenita, DKC1 gene</td><td>Telomere Attrition</td><td>Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome in which the known susceptibility genes (DKC1, TERC, and TERT) belong to the telomere maintenance pathway; patients with DC have very short telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17468339'>17468339</td>
<tr><td>Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17468339'>17468339</td>
<tr><td>Bone Marrow Failure Disorders</td><td>Telomere Attrition</td><td>We used multicolor flow fluorescence in situ hybridization analysis of median telomere length in total blood leukocytes, granulocytes, lymphocytes, and several lymphocyte subsets to confirm the diagnosis of DC, distinguish patients with DC from unaffected family members, identify clinically silent DC carriers, and discriminate between patients with DC and those with other bone marrow failure disorders.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17468339'>17468339</td>
<tr><td>Carcinogenesis</td><td>Telomere Attrition</td><td>Many studies have demonstrated the association between telomere length in mitotic cells and carcinogenesis and mortality, but little attention has been focused on post-mitotic cells and human life expectancy.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17606349'>17606349</td>
<tr><td>Cerebral cortex</td><td>Telomere Attrition</td><td>We assessed the relationship between telomere length in cerebral gray and white matter and longevity in 72 autopsied Japanese patients aged 0-100 years using Southern blot hybridization.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17606349'>17606349</td>
<tr><td>Cancer-Related Death</td><td>Telomere Attrition</td><td>Autopsy protocols showed a decrease in the rate of cancer death in individuals in their 80s (p=0.041) and 90s (p=0.017) versus those in their 60s, and in their 80s the mean telomere length in the gray matter from cancer death patients was significantly shorter than that of patients who died of other diseases (p=0.04).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/17606349'>17606349</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>There was a large difference in the distribution of subjects based on telomere length in tumor and adjacent non-tumor tissues.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18058461'>18058461</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>The relationship between telomere length and cancer risk was particularly strong among NSAID nonusers, ever smokers, and patients with low waist-to-hip ratio.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18086770'>18086770</td>
<tr><td>WBS2 gene, Disease, Werner Syndrome</td><td>Telomere Attrition</td><td>Telomere dysfunction has been proposed to contribute to the pathogenesis of Werner syndrome (WS), a premature-aging disorder.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18212065'>18212065</td>
<tr><td>Alzheimers Disease</td><td>Telomere Attrition</td><td>We report results using a quantitative RTm-PCR method to measure absolute telomere length (in kb per diploid genome) and show the age-related changes in white blood cells and buccal cell telomere length (in kb per diploid genome) in normal healthy individuals and Alzheimers patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18242664'>18242664</td>
<tr><td>Alzheimers Disease</td><td>Telomere Attrition</td><td>We observed a significantly lower telomere length in white blood cells (P < 0.0001) and buccal cells (P < 0.01) in Alzheimers patients relative to healthy age-matched controls (31.4% and 32.3%, respectively).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18242664'>18242664</td>
<tr><td>Alzheimers Disease</td><td>Telomere Attrition</td><td>However, there was a significantly greater telomere length in hippocampus cells of Alzheimers brains (P = 0.01) compared to control samples (49.0%).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18242664'>18242664</td>
<tr><td>Up</td><td>Telomere Attrition</td><td>The odds ratio for AD diagnosis was 4.6 (95% CI 1.22-17.16) if buccal cell telomere length was less than 40 kb per diploid genome with a sensitivity of 72.7% and a specificity of 63.1%.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18242664'>18242664</td>
<tr><td>Electrocardiogram: myocardial infarction (finding), Coronary Artery Disease</td><td>Telomere Attrition</td><td>With this study, we intended to identify the influence of telomere length on bone marrow functionality in 50 patients with coronary artery disease (CAD) and previous myocardial infarction.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18276909'>18276909</td>
<tr><td>Impaired</td><td>Telomere Attrition</td><td>Finally, the telomere length difference between granulocytes and lymphocytes was the most determinant for telomere-associated bone marrow impairment (P<0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18276909'>18276909</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20</td><td>Telomere Attrition</td><td>Telomere length and obesity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18430074'>18430074</td>
<tr><td>Adenocarcinoma, Neoplasms, Carcinoma of lung, Small cell carcinoma of lung, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>When the cases were categorized by tumor histology, the effect of short telomere length on the risk of lung cancer was more pronounced in patients with small cell carcinoma than in those with squamous cell carcinoma and adenocarcinoma (P = 0.001, test for homogeneity).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18452563'>18452563</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>The prognostic value of short telomeres in predicting death is not completely captured by existing clinical, inflammatory, and echocardiographic markers of risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18467646'>18467646</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18467646'>18467646</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>Whether leukocyte telomere length is associated with mortality among patients with stable coronary artery disease (CAD) is unknown.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18467646'>18467646</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>Compared with participants in the highest telomere length quartile, those in the lowest quartile were at increased risk of death (age-adjusted HR 1.8; 95% CI 1.2 to 2.9).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18467646'>18467646</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>After multivariate adjustment for clinical (HR 2.1; CI 1.3 to 3.3), inflammatory (HR 2.0; CI 1.2 to 3.2), and echocardiographic (HR 1.9; CI 1.0 to 3.5) risk factors, patients in the lowest quartile of telomere length remained at significantly increased risk of death compared to those in the highest quartile.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18467646'>18467646</td>
<tr><td>Ulcerative Colitis, Colorectal Carcinoma, Neoplasms, Chromosomal Instability, Chronic inflammatory disorder</td><td>Telomere Attrition</td><td>We explored this hypothesis in ulcerative colitis (UC), a chronic inflammatory disease that predisposes to colorectal cancer and in which shorter telomeres have been associated with chromosomal instability and tumor progression.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18519043'>18519043</td>
<tr><td>Ulcerative Colitis</td><td>Telomere Attrition</td><td>Telomere length was measured by quantitative polymerase chain reaction in colonocytes and leukocytes of 2 different sets of UC patients and compared with normal controls across a wide range of ages.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18519043'>18519043</td>
<tr><td>Ulcerative Colitis</td><td>Telomere Attrition</td><td>gammaH2AX intensity is higher in colonocytes of UC patients than in controls and is not dependent on age or telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18519043'>18519043</td>
<tr><td>Alzheimers Disease", Dementia, Vascular</td><td>Telomere Attrition</td><td>Relative telomere length in patients with late-onset Alzheimers dementia or vascular dementia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18628664'>18628664</td>
<tr><td>VAD I protocol, Up</td><td>Telomere Attrition</td><td>A quantitative real-time PCR method was used to calculate the relative telomere length in 76 age-matched and sex-matched, newly diagnosed late-onset AD or VaD patients recruited from our Memory Unit.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18628664'>18628664</td>
<tr><td>VAD I protocol, Up</td><td>Telomere Attrition</td><td>No significant difference was found in the relative telomere length between AD and VaD cases neither in men (P=0.315) nor women (P=0.12).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18628664'>18628664</td>
<tr><td>VAD I protocol, "Alzheimers Disease", Dementia, Vascular, Up</td><td>Telomere Attrition</td><td>We hypothesized that the relative length of telomeres could discriminate between patients with late-onset Alzheimers disease (AD) and vascular dementia (VaD).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18628664'>18628664</td>
<tr><td>Premature aging syndrome, Diabetes Mellitus</td><td>Telomere Attrition</td><td>To clarify whether diabetes is a premature aging syndrome, we determined telomere erosion dynamics and occurrence of structural chromosomal aberrations in women of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18650367'>18650367</td>
<tr><td>Cardiovascular system, Dyslipidemias, Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>All women at high risk for cardiovascular death have accelerated telomere erosion, not caused by type 2 diabetes per se but likely linked to other risk factors, including dyslipidemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18650367'>18650367</td>
<tr><td>Papillary thyroid carcinoma</td><td>Telomere Attrition</td><td>The aim of our work was to study the telomere-telomerase complex in the peripheral blood of patients with familial papillary thyroid cancer (FPTC), including the measurement of relative telomere length (RTL), telomerase reverse transcriptase (hTERT) gene amplification, hTERT mRNA expression, telomerase protein activity, and search of hTERT or telomerase RNA component gene mutations.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18664542'>18664542</td>
<tr><td>Malignant neoplasm of skin</td><td>Telomere Attrition</td><td>A prospective study of telomere length and the risk of skin cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18668136'>18668136</td>
<tr><td>SERPINB3 wt Allele, melanoma, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>Using quantitative real-time PCR, we prospectively measured relative telomere length in a nested case-control study within the Nurses Health Study: 218 melanoma cases, 285 squamous-cell carcinoma (SCC) cases, 300 basal-cell carcinoma (BCC) cases, and 870 controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18668136'>18668136</td>
<tr><td>melanoma</td><td>Telomere Attrition</td><td>Women in the second and first quartiles, those with the shortest telomere length, had an odds ratio (OR) for melanoma of 0.54 (95% confidence interval (CI), 0.29-1.01) and 0.59 (95% CI, 0.31-1.13), respectively, compared with those in the fourth quartile (P, trend=0.09).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18668136'>18668136</td>
<tr><td>Dyskeratosis Congenita, Bone marrow hypocellularity</td><td>Telomere Attrition</td><td>TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18669893'>18669893</td>
<tr><td>Vascular Diseases</td><td>Telomere Attrition</td><td>Previous studies have suggested that reduced telomere length in circulating leucocytes in humans is associated with premature vascular disease and by implication, accelerated vascular ageing.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18762552'>18762552</td>
<tr><td>HIV Infections</td><td>Telomere Attrition</td><td>Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: contributor to exhaustion?</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18816191'>18816191</td>
<tr><td>HIV Infections</td><td>Telomere Attrition</td><td>Enhanced telomere shortening of EBV-specific T cells was observed during HIV infection, compared with the decline in telomere length observed in the CD8+ T cells of healthy subjects.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18816191'>18816191</td>
<tr><td>HIV Infections</td><td>Telomere Attrition</td><td>We investigated whether the observed chronic EBV loads during HIV infection could cause exhaustion of EBV-specific T cells by using flow-FISH (flow cytometry in combination with fluorescence in situ hybridization) to analyze the telomere length of EBV-specific CD8+ T cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18816191'>18816191</td>
<tr><td>Ulcerative Colitis, Neoplastic disease</td><td>Telomere Attrition</td><td>Three different assays of genomic alterations in nondysplastic UC biopsies show promise for distinguishing patients with neoplasia (UC progressors) from those without (UC nonprogressors), including assays of telomere length, anaphase bridges, and chromosomal fluorescence in situ hybridization.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/18988798'>18988798</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>In conclusion, this demonstrates that, although MDS stroma cells and hematopoietic cells share the same microenvironment, the stromal cells do not share the processes that contribute to accelerated telomere attrition, suggesting that stromal cell proliferative potential is not limiting in MDS.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19050887'>19050887</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>No telomere shortening in marrow stroma from patients with MDS.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19050887'>19050887</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Telomere shortening with age may lead to genomic instability and an increased risk of cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19050887'>19050887</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>qFISH showed comparable rates of decrease in telomere length with age in MDS patients and age-matched healthy controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19050887'>19050887</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>The telomere length of cancer cells was measured by quantitative fluorescence in situ hybridization.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19141026'>19141026</td>
<tr><td>Childhood Leukemia</td><td>Telomere Attrition</td><td>We propose that short and dysfunctional telomeres limit normal stem cell proliferation and predispose for leukemia by selection of stem cells with defective DNA damage responses that are prone to genome instability.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19147845'>19147845</td>
<tr><td>Papillary thyroid carcinoma, Malignant Neoplasms</td><td>Telomere Attrition</td><td>Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19194115'>19194115</td>
<tr><td>Peptichemio</td><td>Telomere Attrition</td><td>To better define the biologic profile of radiation-induced and sporadic PTC, we compared in these two groups of PTC the expression of cell cycle regulatory proteins and telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19194115'>19194115</td>
<tr><td>Peptichemio</td><td>Telomere Attrition</td><td>The other cell cycle markers and telomere length did not differ significantly between sporadic PTC and radiation-induced PTC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19194115'>19194115</td>
<tr><td>Spontaneous abortion, Idiopathic premature ovarian failure, FMR1 wt Allele</td><td>Telomere Attrition</td><td>Telomere-specific quantitative PCR was used to assess telomere length in two groups of women with evidence of reproductive aging: (i) patients with idiopathic premature ovarian failure (POF, N = 34) and (ii) women with a history of recurrent miscarriage (RM, N = 95); and two control groups: (1) women from the general population (C1, N = 108) and (2) women who had a healthy pregnancy after 37 years of age (C2, N = 46).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19202142'>19202142</td>
<tr><td>Schizophrenia</td><td>Telomere Attrition</td><td>Telomere content (which is highly correlated with telomere length) and PP were measured in newly diagnosed, antipsychotic-naive patients with schizophrenia and related disorders on first clinical contact and in matched control subjects.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19279086'>19279086</td>
<tr><td>Postmenopausal state, Primary malignant neoplasm, Breast Carcinoma</td><td>Telomere Attrition</td><td>We used quantitative real-time PCR to measure relative telomere length in genomic DNA extracted from peripheral blood leukocytes and examined its association with postmenopausal breast cancer risk in 1,122 invasive breast cancer cases and 1,147 matched controls free of diagnosed cancer nested within the prospective Nurses Health Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19293310'>19293310</td>
<tr><td>FGR protein, human</td><td>Telomere Attrition</td><td>Southern analysis of telomere length for placenta and cord blood samples from 32 FGR and 36 control donors, ranging in gestational age from 37 to 40 weeks, revealed significantly shorter telomeres (P<or=0.001) in FGR placenta samples, but not cord blood samples.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19359039'>19359039</td>
<tr><td>FGR protein, human</td><td>Telomere Attrition</td><td>Here we examine whether telomere length maintenance is also compromised in FGR placenta samples.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19359039'>19359039</td>
<tr><td>Unknown (origin) (qualifier value), FGR protein, human</td><td>Telomere Attrition</td><td>Furthermore, analysis of telomerase extracts, RNA and DNA placental samples from donors with and without idiopathic FGR confirmed a direct association between suppression of telomerase activity and reduced telomere length in FGR placenta.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19359039'>19359039</td>
<tr><td>Degenerative disorder, Neoplasm Metastasis</td><td>Telomere Attrition</td><td>Critically short telomeres have been described in degenerative diseases and secondary malignancies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19411630'>19411630</td>
<tr><td>Chronic graft-versus-host disease</td><td>Telomere Attrition</td><td>Chronic graft-versus-host disease (P < .04) and a female donor (P < .04) were associated with a greater difference in telomere length between donor and recipient.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19411630'>19411630</td>
<tr><td>ROBO3 gene</td><td>Telomere Attrition</td><td>Our results suggest that mutant lamin A decreases telomere length via a direct effect and that expression of mutant LMNA is necessary for telomere loss in HGPS.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19428457'>19428457</td>
<tr><td>ZMPSTE24 gene</td><td>Telomere Attrition</td><td>Telomere length in Hutchinson-Gilford progeria syndrome.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19428457'>19428457</td>
<tr><td>ROBO3 gene</td><td>Telomere Attrition</td><td>Previous research has shown that the average telomere length in fibroblasts from HGPS patients is shorter than in age-matched controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19428457'>19428457</td>
<tr><td>ROBO3 gene</td><td>Telomere Attrition</td><td>In contrast, the telomere length in hematopoietic cells which typically do not express lamin A, was within the normal range for three out of four HGPS patient samples.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19428457'>19428457</td>
<tr><td>Hematologic Neoplasms</td><td>Telomere Attrition</td><td>Short telomeres result from a specific defect of telomere maintenance in DC and likely from higher cellular turnover in AA and hematological malignancies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19489057'>19489057</td>
<tr><td>Dyskeratosis Congenita, Hematologic Neoplasms, Aplastic Anemia</td><td>Telomere Attrition</td><td>The determination of telomere length is useful for the characterization of dyskeratosis congenita (DC) and of aplastic anemias (AA) as well as hematological malignancies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19489057'>19489057</td>
<tr><td>Bone marrow hypocellularity</td><td>Telomere Attrition</td><td>Our aim was to evaluate the utility of a qPCR method for telomere length assessment to evaluate the diagnostic contribution of telomere measurement in bone marrow failure syndromes (BMFS).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19489057'>19489057</td>
<tr><td>Breast Carcinoma</td><td>Telomere Attrition</td><td>Using the 50th percentile value in controls as a cut point, women who had shorter telomere length were not at significantly increased risk of breast cancer compared with women who had longer telomere length in the RPCI study (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 0.84-2.12), in the LCCC study (OR = 1.18, 95% CI = 0.73-1.91), or in the combined RPCI and LCCC studies (OR = 1.23, 95% CI = 0.89-1.71).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19543829'>19543829</td>
<tr><td>Cholestanes</td><td>Telomere Attrition</td><td>HBV-related LLCC showed significantly higher Tp53 labeling index, gamma-H2AX labeling index, and micronuclei index; shorter telomere length; decreased SA-beta-Gal activity; and increased net cellular gain compared to cholestatic LLCC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19585549'>19585549</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Telomerase expression and the maintenance of a critical telomere length (TL) in cancer initiation indicates that telomere shortening and telomerase expression initiates cancer by induction of chromosomal instability.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19627485'>19627485</td>
<tr><td>FAM126A gene</td><td>Telomere Attrition</td><td>It was also found that shorter telomeres are present in telomerase-positive HCC cases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19627485'>19627485</td>
<tr><td>Liver carcinoma, Hepatitis B virus status</td><td>Telomere Attrition</td><td>Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19627485'>19627485</td>
<tr><td>Hepatitis, FAM126A gene</td><td>Telomere Attrition</td><td>The mean telomere length (MTL) in HCC was significantly shorter compared with chronic hepatitis (P<0.0001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19627485'>19627485</td>
<tr><td>Inflammation</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) decreases over the adult life course owing to the cumulative burden of oxidative stress, inflammation, and exposure to vascular risk factors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19752323'>19752323</td>
<tr><td>Hypertensive (finding)</td><td>Telomere Attrition</td><td>Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19772655'>19772655</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>Attempt has also been made to find out whether telomere length attrition is associated with hypertension and obese individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19772655'>19772655</td>
<tr><td>Hypertensive (finding)</td><td>Telomere Attrition</td><td>After adjusting the influence of age and gender, the analysis of co-variance (ANCOVA) revealed the relative telomere length (T/S ratio) in hypertensive individuals to be (1.01 +/- 0.021), which was significantly different (P < 0.001) from obese (1.20 +/- 0.023) and normal (1.22 +/- 0.014) individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19772655'>19772655</td>
<tr><td>Hypertensive (finding)</td><td>Telomere Attrition</td><td>The present study revealed that allelic association at ApoB, LPL, Leptin loci and loss of telomere length may have strong genetic association with hypertensive individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19772655'>19772655</td>
<tr><td>NDUFB3 gene</td><td>Telomere Attrition</td><td>We investigated the relationship between telomere length in peripheral blood lymphocytes and plasma FOL, B12, and HCY status, and tested whether any such relationship was dependent on age, gender, body mass index, and common polymorphisms in folate metabolism genes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19785508'>19785508</td>
<tr><td>Malignant Neoplasms, Premature tooth loss</td><td>Telomere Attrition</td><td>We have found heritable hypomorphic TERT mutations in other cancers as well, and we propose that such mutations result in short telomeres and premature loss of stem cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19796246'>19796246</td>
<tr><td>Stomach Carcinoma</td><td>Telomere Attrition</td><td>In a population-based study of gastric cancer conducted in a high-risk population in Warsaw, Poland, between 1994 and 1996, we measured relative telomere length in 300 cases and 416 age- and gender-matched controls using quantitative real-time PCR.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19861514'>19861514</td>
<tr><td>Rheumatism</td><td>Telomere Attrition</td><td>Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Rheumatism</td><td>Telomere Attrition</td><td>We measured mean telomere length in peripheral blood leukocytes (PBL) from patients with various rheumatologic diseases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Right arm, Arthritis, Psoriatic, Rheumatoid Arthritis, Spondylitis</td><td>Telomere Attrition</td><td>Mean PBL telomere length was measured using real-time quantitative polymerase chain reaction (Q-PCR) assay in a control population (n=130; age range: 3-94 years) and in subjects diagnosed with rheumatoid arthritis (RA; n=86; age range: 31-82 years), psoriatic arthritis (PA; n=56; age range: 26-79 years) and ankylosing spondylitis (AS; n=59; age range: 21-75 years).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Degenerative polyarthritis, Osteoporosis, Disease</td><td>Telomere Attrition</td><td>Telomere length was also quantified in subjects with osteoarthritis (OA; n=34; age range: 43-82 years) and osteoporosis (OP; n=35; age range: 59-95 years), diseases without a chronic systemic inflammatory component.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Degenerative polyarthritis</td><td>Telomere Attrition</td><td>Telomere length in OA showed no differences from age-matched controls (p=0.234), but was significantly shorter in OP (p=0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Right arm</td><td>Telomere Attrition</td><td>Telomere length was significantly longer than controls in RA (p=0.015), PA (p<0.001) and AS (p<0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Pathology, Inflammation</td><td>Telomere Attrition</td><td>Different patterns in telomere length from PBL are evidenced in rheumatologic pathologies, possibly dependent on the presence or absence of chronic systemic inflammation.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19879280'>19879280</td>
<tr><td>Myeloid Leukemia, Chronic, Malignant Neoplasms</td><td>Telomere Attrition</td><td>As in the case of most cancers, the average telomere length in CML cells is shorter than that in normal blood cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19881950'>19881950</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>However, there are currently no data available concerning specific individual telomere length in CML.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19881950'>19881950</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>Here, we studied telomere length on each chromosome arm of CML cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19881950'>19881950</td>
<tr><td>Myeloid Leukemia, Chronic, Chromosome Aberrations</td><td>Telomere Attrition</td><td>We propose a possible involvement of individual telomere length changes to some chromosomal abnormalities in CML.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19881950'>19881950</td>
<tr><td>Childhood Leukemia</td><td>Telomere Attrition</td><td>We suggest that individual telomere length maintenance is chromosome arm-specific associated with leukemia cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19881950'>19881950</td>
<tr><td>Carcinogenesis</td><td>Telomere Attrition</td><td>It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of the DNA damage response machinery.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19884805'>19884805</td>
<tr><td>Carcinogenesis</td><td>Telomere Attrition</td><td>We explored telomere length modification and damage response pathway activation at 3 steps of breast carcinogenesis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19884805'>19884805</td>
<tr><td>Idiopathic Pulmonary Fibrosis, Congenital Bone Marrow Failure Syndromes, Aplastic Anemia</td><td>Telomere Attrition</td><td>Loss-of-function mutations cause critical telomere shortening and are associated with the bone marrow failure syndromes dyskeratosis congenita and aplastic anemia and with idiopathic pulmonary fibrosis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19936245'>19936245</td>
<tr><td>Idiopathic Pulmonary Fibrosis, Fibrosis Assessment, Leukemia, Myelocytic, Acute, Autoimmune Diseases, Inflammation, Liver diseases, Macrocytosis result</td><td>Telomere Attrition</td><td>In six generations of a large family, a loss-of-function mutation in the telomerase enzyme gene TERT associated with severe telomere shortening and a range of hematologic manifestations, from macrocytosis to acute myeloid leukemia, with severe liver diseases marked by fibrosis and inflammation, and one case of idiopathic pulmonary fibrosis but not with autoimmune disorders.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19936245'>19936245</td>
<tr><td>Autoimmune Diseases, Hematologic</td><td>Telomere Attrition</td><td>Sixty-nine individuals from five unrelated families with a variety of hematologic, hepatic, and autoimmune disorders were screened for telomerase complex gene mutations; leukocyte telomere length was measured by flow fluorescence in situ hybridization in mutation carriers and some non-carriers; the effects of the identified mutations on telomerase activity were determined; and genetic and clinical data were correlated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19936245'>19936245</td>
<tr><td>Diabetes Mellitus, Heart failure, Atrial Fibrillation by ECG Finding, Cerebrovascular accident, Cessation of life</td><td>Telomere Attrition</td><td>In multivariate analysis shorter telomere length remained associated with a higher risk for death or hospitalization (hazard ratio, 1.74; 95% CI 1.07-2.95) after adjustment for age of heart failure onset, gender, hemoglobin, renal function, and N-terminal pro-B-type natriuretic peptide level, a history of stroke, atrial fibrillation, and diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/19941413'>19941413</td>
<tr><td>Keratoconus</td><td>Telomere Attrition</td><td>The difference of telomere length in stromal cells of keratoconus and normal corneas reached a statistical significant level (t = 4.753, P < 0.05).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20021886'>20021886</td>
<tr><td>Down Syndrome</td><td>Telomere Attrition</td><td>We also show for the first time that telomere length attrition may be associated in some way with meiosis I and meiosis II nondisjunction of chromosome 21 and subsequent Down syndrome births at advanced maternal age.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20063167'>20063167</td>
<tr><td>Muscular Dystrophy, Duchenne</td><td>Telomere Attrition</td><td>Telomere shortening is thought to contribute to premature senescence of satellite cells in Duchenne muscular dystrophy (DMD) muscle.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20137830'>20137830</td>
<tr><td>Aortic Aneurysm, Abdominal</td><td>Telomere Attrition</td><td>The mean white cell telomere length was significantly lower in AAA patients compared to controls (median age 66 years in both groups), with a mean difference of 189 base pairs (bp) (95% confidence interval 77 bp to 301 bp, P=0.005).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20172749'>20172749</td>
<tr><td>Anemia</td><td>Telomere Attrition</td><td>One standard deviation shorter telomere length was associated with an increased risk of having anaemia [odds ratio (OR), 1.31; 95% confidence interval (CI), 1.12-1.53; P = 0.001].</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20335352'>20335352</td>
<tr><td>Anemia, Congestive heart failure</td><td>Telomere Attrition</td><td>Shorter telomere length increases the odds of having anaemia in CHF patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20335352'>20335352</td>
<tr><td>Breast Carcinoma, Colorectal Carcinoma</td><td>Telomere Attrition</td><td>In the retrospective SEARCH studies, the age-adjusted odds ratios for shortest (Q4) versus longest (Q1) quartile of mean telomere length was 15.5 [95% confidence intervals (CI), 11.6-20.8; p-het = 5.7 x 10(-75)], with a "per quartile" P-trend = 2.1 x 10(-80) for breast cancer; and 2.14 (95% CI, 1.77-2.59; p-het = 7.3 x 10(-15)), with a per quartile P-trend = 1.8 x 10(-13) for colorectal cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20395204'>20395204</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20570912'>20570912</td>
<tr><td>melanoma, Colorectal</td><td>Telomere Attrition</td><td>We evaluated the association between single nucleotide polymorphism (SNP) rs401681 (C > T) and mean telomere length, using quantitative real-time PCR, in blood-extracted DNA collected from 11,314 cancer-free participants from the Sisters in Breast Screening study, the Melanoma and Pigmented Lesions Evaluative Study melanoma family study, and the SEARCH Breast, Colorectal, Melanoma studies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20570912'>20570912</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>The lack of an association in our study between this SNP and mean telomere length suggests that any association with cancer risk at this locus is not mediated through TERT.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20570912'>20570912</td>
<tr><td>Migraine Disorders</td><td>Telomere Attrition</td><td>Shorter telomere length in peripheral blood cells associated with migraine in women.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20618815'>20618815</td>
<tr><td>Migraine Disorders</td><td>Telomere Attrition</td><td>A regression analysis was performed to assess differences in mean relative telomere length between migraine patients and healthy controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20618815'>20618815</td>
<tr><td>Migraine Disorders</td><td>Telomere Attrition</td><td>A significantly shorter relative telomere length was observed in the migraine group compared with the control group after adjusting for age and body mass index (P = .001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20618815'>20618815</td>
<tr><td>Migraine Disorders</td><td>Telomere Attrition</td><td>No association was observed between relative telomere length and the severity and frequency of migraine attacks and the duration of migraine.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20618815'>20618815</td>
<tr><td>Prostate carcinoma</td><td>Telomere Attrition</td><td>Telomere shortening can be one of the ways that cause chromosomal instability in the pathogenesis of prostatic carcinoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20674190'>20674190</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Univariate analysis revealed inverse correlation between telomere shortening in tumor and Gleason scores (p=0.017).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20674190'>20674190</td>
<tr><td>Adenocarcinoma of prostate</td><td>Telomere Attrition</td><td>Telomere shortening is a common alteration in prostatic adenocarcinoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20674190'>20674190</td>
<tr><td>Malignant neoplasm of prostate</td><td>Telomere Attrition</td><td>The majority (49/61) of prostate cancers displayed abnormally short telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20674190'>20674190</td>
<tr><td>Neoplasms, Malignant neoplasm of prostate</td><td>Telomere Attrition</td><td>In the current study, we evaluated telomere length (TL) in normal and malignant prostate tissues, and its association with prognostic factors and with time to biochemical tumor recurrence.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20674190'>20674190</td>
<tr><td>selenium</td><td>Telomere Attrition</td><td>Telomere length was greater in the African-American adolescents than in the Caucasian adolescents (age- and sex-adjusted T/S ratio +- SE, 1.32 +- 0.01 vs 1.27 +- 0.01: P = .014) and greater in girls than in boys (age- and race-adjusted T/S ratio +- SE, 1.31 +- 0.01 vs 1.27 +- 0.01; P = .007).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20855079'>20855079</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Telomere length is a prognostic factor for overall survival in colorectal cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20874798'>20874798</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>The aim of this study was to determine whether telomere length is an independent prognostic factor for the prevention and survival of colorectal cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20874798'>20874798</td>
<tr><td>Neoplasms, Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Telomere length ratio is an independent prognostic factor for survival in colorectal cancer patients, and the telomere lengths in the normal and tumour mucosa of the same patient present with parallel behaviour.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/20874798'>20874798</td>
<tr><td>Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Mutations in genes for telomere binding proteins or components of telomerase give rise to the premature aging disorder dyskeratosis congenita (DC), which is characterized by extremely short telomeres and an aging phenotype.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21087144'>21087144</td>
<tr><td>BONE MARROW FAILURE SYNDROME 1, Congenital Bone Marrow Failure Syndromes, Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Patients with dyskeratosis congenita (DC), an inherited bone marrow failure syndrome (IBMFS), have mutations in telomere biology genes, and very short telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21113082'>21113082</td>
<tr><td>Childhood Leukemia</td><td>Telomere Attrition</td><td>Simultaneous analysis of telomere length and cell surface antigen in leukemia by multicolor Flow-FISH.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21176337'>21176337</td>
<tr><td>Childhood Leukemia</td><td>Telomere Attrition</td><td>The telomere length in 34 leukemia patients versus 20 normal controls was compared by using Flow-FISH, and the relationship between telomere length and therapeutic effect and prognosis was analyzed preliminarily.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21176337'>21176337</td>
<tr><td>Leukemia, Myeloid, Chronic-Phase</td><td>Telomere Attrition</td><td>The results indicated that the telomere length of de novo patients was significantly shorter than that of controls except the patients in chronic myeloid leukemia-chronic phase (CML-CP).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21176337'>21176337</td>
<tr><td>Common Variable Immunodeficiency</td><td>Telomere Attrition</td><td>Telomere lengths in B and T cells were significantly correlated, indicating that the rate of telomere attrition in lymphocytes is an individual characteristic of CVID patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21287551'>21287551</td>
<tr><td>Disease</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) is related to diseases of aging, but studies of mortality have been inconsistent.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21289018'>21289018</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Diabetes Mellitus, Non-Insulin-Dependent, Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Obesity in adults is associated with shorter mean leukocyte telomere length (LTL), a marker of biological age that is also associated with age-related conditions including cardiovascular disease and type 2 diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21349907'>21349907</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20</td><td>Telomere Attrition</td><td>The objective of the study was to clarify the relationship between telomere length and childhood obesity by measuring the average LTL in a large case-control cohort.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21349907'>21349907</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Shorter telomere length (TL) in peripheral blood leucocytes (PBLs), a marker of biological aging, has been associated with alcohol-related cancer risks.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21351086'>21351086</td>
<tr><td>Skin carcinoma</td><td>Telomere Attrition</td><td>No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21357377'>21357377</td>
<tr><td>Squamous cell carcinoma of skin, Experimental Organism Basal Cell Carcinoma</td><td>Telomere Attrition</td><td>We prospectively evaluated the association of telomere length in peripheral blood leukocytes with the risk of skin squamous cell carcinoma (SCC) in 241 cases and 241 controls within the Health Professionals Follow-up Study (HPFS), and the risk of skin basal cell carcinoma (BCC) in 623 cases and 1,943 controls within the Nurses Health Study (NHS).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21357377'>21357377</td>
<tr><td>Skin carcinoma</td><td>Telomere Attrition</td><td>We found no evidence that telomere length in peripheral blood leukocytes was associated with risk of nonmelanoma skin cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21357377'>21357377</td>
<tr><td>Skin carcinoma</td><td>Telomere Attrition</td><td>Our prospective study suggests that telomere length in peripheral blood leukocytes is less likely to play a substantial role in nonmelanoma skin cancer development.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21357377'>21357377</td>
<tr><td>Premature aging syndrome, Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Dyskeratosis congenita (DC) is a premature ageing syndrome characterised by short telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21415081'>21415081</td>
<tr><td>Ovarian Carcinoma, Adenocarcinoma, Clear Cell</td><td>Telomere Attrition</td><td>Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21499239'>21499239</td>
<tr><td>ovarian neoplasm</td><td>Telomere Attrition</td><td>Alteration of telomerase activity has been reported in ovarian tumors but the pattern of telomere length in their specific histological subtypes has not been reported.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21499239'>21499239</td>
<tr><td>Carcinoma</td><td>Telomere Attrition</td><td>The mean relative telomere length of carcinoma to stromal cells was calculated as a telomere index.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21499239'>21499239</td>
<tr><td>Ovarian Carcinoma</td><td>Telomere Attrition</td><td>In conclusion, our results provide new evidence that telomere length significantly differs by histologic type in ovarian carcinoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21499239'>21499239</td>
<tr><td>Neoplasms, Adenocarcinoma, Clear Cell</td><td>Telomere Attrition</td><td>Specifically, clear cell carcinomas have longer mean relative telomere lengths compared with the other histologic types and longer telomeres in clear cell carcinoma are associated with increased mortality suggesting that aberrations in telomere length may have an important role in the development and progression of this neoplasm.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21499239'>21499239</td>
<tr><td>Carcinoma of lung</td><td>Telomere Attrition</td><td>Compared to subjects with shorter telomere length (<=median), subjects with greater telomere length (>median) had a 1.6-fold (95% CI, 1.06-2.36) increased risk of lung cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21507503'>21507503</td>
<tr><td>Carcinoma of lung</td><td>Telomere Attrition</td><td>In addition, subgroup analysis showed that greater telomere length was associated with an increased risk of lung cancer among longer-term smokers (>38 years) (OR, 1.90; 95% CI, 1.00-3.59) but not among shorter-term smokers (<=38 years) (OR, 1.08; 95% CI, 0.56-2.11) (P(interaction)=0.01).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21507503'>21507503</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent, Complications of Diabetes Mellitus</td><td>Telomere Attrition</td><td>As a consequence, this study aimed to verify whether leukocyte telomere length is associated with the presence and the number of diabetic complications in a sample of patients with Type 2 diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21692845'>21692845</td>
<tr><td>Premature aging syndrome, WBS2 gene, Werner Syndrome</td><td>Telomere Attrition</td><td>Many data pertaining to the accelerated telomere loss in cultured cells derived from Werner syndrome (WS), a representative premature aging syndrome, have been accumulated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21732564'>21732564</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>Increased telomere shortening has been demonstrated in several diseases including type 2 diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21824049'>21824049</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>We found a greater telomere shortening in group (A) with type 2 diabetes of 10 years or more since original diagnosis, compared with the control group (C) of healthy males (5.4 vs 9.6 Kb) (p = 0.04) and with group B (5.4 vs 8.7 kb) (p = 0.05).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21824049'>21824049</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>Telomere shortening increases with the duration of diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21824049'>21824049</td>
<tr><td>Premature aging syndrome, Diabetes Mellitus</td><td>Telomere Attrition</td><td>Telomere length and type 2 diabetes in males, a premature aging syndrome.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21824049'>21824049</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>However, it is not known whether telomere length changes during the course of type 2 diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21824049'>21824049</td>
<tr><td>Neoplasms, Peptichemio</td><td>Telomere Attrition</td><td>Our results demonstrate that short telomeres are a consistent feature of PTC, which in familial cases, is not restricted to the tumor tissue.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21865371'>21865371</td>
<tr><td>Pneumonia, Chronic obstructive pulmonary disease of horses</td><td>Telomere Attrition</td><td>Telomere dysfunction and premature P-EC senescence are major processes perpetuating lung inflammation in COPD.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21885626'>21885626</td>
<tr><td>BONE MARROW FAILURE SYNDROME 1, Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by exceedingly short telomeres and mutations in telomere biology genes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21981348'>21981348</td>
<tr><td>Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>The relationship between DNA methylation and telomere length in dyskeratosis congenita.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/21981348'>21981348</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22005790'>22005790</td>
<tr><td>Disease, S100A4 protein, human</td><td>Telomere Attrition</td><td>These results provide the first clinical direct evidence in humans that short telomeres in hematopoietic cells are dysfunctional, mediate chromosomal instability and predispose to malignant transformation in a human disease.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22005790'>22005790</td>
<tr><td>Renal Cell Carcinoma</td><td>Telomere Attrition</td><td>Two small hospital-based case-control studies suggested an association between short blood telomere length (TL) and increased RCC risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22033273'>22033273</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>In multivariate analyses among controls, increasing age and history of hypertension were associated with shorter TL (P<0.001 and P=0.07, respectively), and African Americans had longer TL than Caucasians (P<0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22033273'>22033273</td>
<tr><td>Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Patients with dyskeratosis congenita have accelerated telomere shortening.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22058220'>22058220</td>
<tr><td>Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>In the first longitudinal follow up of dyskeratosis congenita patients, we demonstrate that telomere lengths decline with age, in contrast to the apparent stable telomere length observed in cross-sectional data.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22058220'>22058220</td>
<tr><td>Dyskeratosis Congenita, Bone marrow hypocellularity</td><td>Telomere Attrition</td><td>Telomere length by flow fluorescence in situ hybridization is an important diagnostic test for dyskeratosis congenita; age-adjusted values provide a quantitative measure of disease severity (clinical subset, mutated gene, and degree of bone marrow failure).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22058220'>22058220</td>
<tr><td>Dysplasia, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>Ortho-keratotic dysplasia was frequently associated with squamous cell carcinoma (45.0%) and showed significantly shorter telomeres than normal control epithelium, CIS, or the background of CIS or OKD.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22122732'>22122732</td>
<tr><td>Leukoplakia, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>In an attempt to clarify the relationship between OKD as a precancerous condition in the oral mucosa and telomere length, we estimated telomere lengths in this type of leukoplakia using quantitative fluorescence in situ hybridization, and also quantified the frequency of anaphase-telophase bridges (ATBs) in comparison with squamous cell carcinoma in situ (CIS) and the background tissues of CIS and OKD.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22122732'>22122732</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>This study investigated the relation between leucocyte telomere length (LTL) and its genetic background to cardiac structure and function in patients with arterial hypertension.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22314626'>22314626</td>
<tr><td>Neoplasms, Neuroblastoma</td><td>Telomere Attrition</td><td>Somatic recurrent mutations in tumors from patients with neuroblastoma correlated with the age at diagnosis and telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22416102'>22416102</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20</td><td>Telomere Attrition</td><td>Premature biological ageing, assessed by reduction in telomere length (TL), may be mediated by factors resulting from altered metabolic profiles associated with obesity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22474429'>22474429</td>
<tr><td>Cytopenia</td><td>Telomere Attrition</td><td>Telomere dysfunction might generate genomic instability leading to cytopenias and disease progression.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22539801'>22539801</td>
<tr><td>PAFAH1B1 wt Allele, Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>Three-dimensional telomeric profiles are linked to the evolution of telomere dysfunction, defining a model of progression from MDS to AML.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22539801'>22539801</td>
<tr><td>PAFAH1B1 wt Allele, Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>Our results show distinct three-dimensional telomeric profiles specific to patients with MDS and AML that help subgroup patients based on the severity of telomere dysfunction highlighted in the profiles.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22539801'>22539801</td>
<tr><td>Myeloid Leukemia, Chronic</td><td>Telomere Attrition</td><td>Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/22687638'>22687638</td>
<tr><td>Depression, CTCAE, Usual Severity Pain</td><td>Telomere Attrition</td><td>When pain and depression were combined, patients categorized as high-pain/high-depression had an age-adjusted telomere length 265 base pairs shorter than those with low-pain/low-depression (P = .043), a difference consistent with approximately 6 years of chronological aging.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23031395'>23031395</td>
<tr><td>PAFAH1B1 wt Allele, NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology</td><td>Telomere Attrition</td><td>Accelerated telomere attrition in patients with myelodysplastic syndrome (MDS) occurs by an undefined mechanism.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23072779'>23072779</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>In MDS cases, we show that purified CD3+ T-cells have significantly shorter telomere length and reduced proliferative capacity upon stimulation compared with controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23072779'>23072779</td>
<tr><td>Hypertensive disease, Left Ventricular Hypertrophy, Ventricular hypertrophy</td><td>Telomere Attrition</td><td>We measured leucocyte telomere length (LTL) by Southern blot and analysed ACE I/D genotypes in 1249 subjects with hypertension and left ventricular hypertrophy (LVH).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23077078'>23077078</td>
<tr><td>Endothelial dysfunction, atherosclerotic</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) provides a potential marker of biological age, closely related to the endothelial dysfunction and consequently to the atherosclerotic process.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23145125'>23145125</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>These assays, which measure telomere length and telomerase activity of tumor extracts, are conventionally used to classify tumor TMM.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23260199'>23260199</td>
<tr><td>Chronic Obstructive Airway Disease, Chronic obstructive pulmonary disease of horses</td><td>Telomere Attrition</td><td>A previous case-control study of 100 individuals found that short telomere length was associated with a 28-fold increased risk of chronic obstructive pulmonary disease (COPD).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23268483'>23268483</td>
<tr><td>melanoma</td><td>Telomere Attrition</td><td>However, shorter telomeres have also been found to decrease melanoma risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23300679'>23300679</td>
<tr><td>melanoma, Dysplastic Nevus</td><td>Telomere Attrition</td><td>In addition, we examined whether telomere length measured in peripheral blood leukocytes is related to the risk of melanoma, dysplastic nevi, number of nevi, or telomere-related SNPs.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23300679'>23300679</td>
<tr><td>Cerebrovascular accident, Venous Stroke</td><td>Telomere Attrition</td><td>Individuals with shorter telomere length had a higher presence of atherothrombotic stroke {multivariate OR (odds ratio) 1.37 [95% CI (confidence interval), 1.06-1.77]; P=0.015} or haemorrhagic stroke [multivariate OR 1.48 (95% CI, 1.08-2.02); P=0.016] in comparison of the lowest to highest tertile of telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23323942'>23323942</td>
<tr><td>Malignant Neoplasms</td><td>Telomere Attrition</td><td>Previous epidemiologic studies have indicated that shorter telomere length in peripheral blood leukocytes (PBLs) is associated with the development of many cancers.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23408253'>23408253</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Short telomere length, cancer survival, and cancer risk in 47102 individuals.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23468462'>23468462</td>
<tr><td>Primary malignant neoplasm, Cessation of life</td><td>Telomere Attrition</td><td>We therefore tested the hypotheses that short telomere length was associated with increased risk of cancer and with increased risk of early death after cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23468462'>23468462</td>
<tr><td>Chronic myeloproliferative disorder</td><td>Telomere Attrition</td><td>The purpose of this study was to investigate telomere length (TL) in Ph-negative chronic myeloproliferative neoplasms (Ph-neg-CMNs), and the possible association of TL with disease progression and hydroxycarbamide (HU) treatment.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23542632'>23542632</td>
<tr><td>Pancreatic carcinoma, Smoking, Diabetes Mellitus</td><td>Telomere Attrition</td><td>Smoking and diabetes, consistent risk factors for pancreatic cancer, are also factors that influence telomere length maintenance.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23674344'>23674344</td>
<tr><td>Pancreatic carcinoma</td><td>Telomere Attrition</td><td>This is the first prospective study to suggest an association between longer blood leukocyte telomere length and increased pancreatic cancer risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23674344'>23674344</td>
<tr><td>Primary malignant neoplasm, Metastasis, Malignant neoplasm of prostate</td><td>Telomere Attrition</td><td>In this prospective study, the combination of more variable telomere length among cancer cells and shorter telomere length in CAS cells was strongly associated with progression to metastasis and prostate cancer death, pointing to the translational potential for prognostication and risk stratifi cation for individualized therapeutic and surveillance strategies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23779129'>23779129</td>
<tr><td>Depression, CTCAE</td><td>Telomere Attrition</td><td>Telomere length was correlated to perceived stress (r=0.77; p=0.0001) but not to depression in our population.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23917070'>23917070</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Given that HPV16 can affect telomerase activity and telomere length, we conjectured that telomere length in peripheral blood lymphocytes (PBL) might affect the risk of HPV16-associated OPC and tumor HPV16 status in patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23928994'>23928994</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Furthermore, short telomere length was also associated significantly with tumor HPV-positive OPC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23928994'>23928994</td>
<tr><td>Cocaine-Related Disorders, Diabetes Mellitus</td><td>Telomere Attrition</td><td>Telomeres play a central role in cellular aging, and shorter telomere length has been associated with age-related disorders including diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23949319'>23949319</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>In a well-characterized longitudinal cohort of American Indians participating in the Strong Heart Family Study, we examined whether leukocyte telomere length (LTL) at baseline predicts incident diabetes independent of known diabetes risk factors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23949319'>23949319</td>
<tr><td>Skin Basal Cell Carcinoma, melanoma</td><td>Telomere Attrition</td><td>We identified a telomere length-independent but progression-dependent increase in cells with small telomere associations in AKs (17/17) and additional TAs in SCCs (24/32), basal cell carcinomas (30/31) and malignant melanomas (15/15), and provide evidence for a reactive oxygen species-dependent mechanism in this UV-induced telomere organization-dependent genomic instability.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/23955078'>23955078</td>
<tr><td>Cirrhotic, Neoplasms, FAM126A gene, Non-cirrhotic</td><td>Telomere Attrition</td><td>Alterations in TA, hTERT expression and telomere length between non-cirrhotic, cirrhotic, and tumor samples were not significantly influenced by the cause of HCC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24020493'>24020493</td>
<tr><td>Early-onset, Ulcerative Colitis, Late Onset Disorders, Neoplastic disease</td><td>Telomere Attrition</td><td>Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24097228'>24097228</td>
<tr><td>Primary malignant neoplasm, Dysplasia</td><td>Telomere Attrition</td><td>We have previously reported that cancer progression is associated with the presence of clonal expansions and shorter telomeres in nondysplastic mucosa.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24097228'>24097228</td>
<tr><td>Dysplasia, Ulcerative Colitis</td><td>Telomere Attrition</td><td>Clonal expansions and shorter telomeres were more frequent in nondysplastic biopsies from UC progressors than nonprogressors, but only for patients with early-onset of UC (diagnosis at younger than 50 years of age).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24097228'>24097228</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Early-onset progressors develop cancer in a field of clonally expanded epithelium with shorter telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24097228'>24097228</td>
<tr><td>Dysplasia</td><td>Telomere Attrition</td><td>For each patient, a mean of 5 nondysplastic biopsies from proximal, mid, and distal colon were assessed for clonal expansions, as determined by clonal length altering mutations in polyguanine tracts, and telomere length, as measured by quantitative PCR.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24097228'>24097228</td>
<tr><td>Aplastic Anemia, CDISC SDTM Immunogenicity Specimen Assessments Test Name Terminology</td><td>Telomere Attrition</td><td>To observe the changes of telomere length and telomerase activity in patients with aplastic anemia (AA), and relationship with immunosuppressive therapy (IST) efficacy, to explore the pathogenesis of AA and the role of telomere length in evaluating immunosuppressive therapy efficacy.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24103875'>24103875</td>
<tr><td>North Star Ambulatory Assessment Clinical Classification</td><td>Telomere Attrition</td><td>Telomere length and age showed negative correlation (b=-0.387, P=0.001) in normal control, NSAA and SAA + VSAA groups, telomere length became shorter with the growth of age, and normal control group telomere length decreased along with the age growth slightly greater than the other two groups (NSAA, SAA+VSAA).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24103875'>24103875</td>
<tr><td>North Star Ambulatory Assessment Clinical Classification</td><td>Telomere Attrition</td><td>Besides the effect of age on telomere length, no significant difference was observed between NSAA and SAA+VSAA groups (P=0.573), and NSAA, SAA+VSAA (30.957 +- 4.502,29.510 +- 5.911)groups were significantly shorter than normal control group (51.086+-10.844) (P<0.01).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24103875'>24103875</td>
<tr><td>CDISC SDTM Immunogenicity Specimen Assessments Test Name Terminology</td><td>Telomere Attrition</td><td>Telomere length below 29.21% obviously decreased outcomes of IST.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24103875'>24103875</td>
<tr><td>Peptichemio, Metastasis</td><td>Telomere Attrition</td><td>In PTC patients, these mutations were exclusively present in the group with age >45 years (P<0.0001), and highly correlated shorter telomeres (P<0.0001) and distant metastasis (P=0.028).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24141777'>24141777</td>
<tr><td>Glioma</td><td>Telomere Attrition</td><td>Therefore, we evaluated the association between relative telomere length (RTL) and glioma in a prospective study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24231251'>24231251</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Up-regulated expression of telomerase reverse transcriptase (TERT) and subsequent maintenance of telomere length are essential in tumour development.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24338723'>24338723</td>
<tr><td>Primary Biliary Cholangitis</td><td>Telomere Attrition</td><td>Telomere loss correlated with age, suggesting premature cellular ageing in patients with primary biliary cirrhosis.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24378524'>24378524</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>The relative telomere length (RTL) was measured in peripheral blood leukocytes (PBLs) using quantitative real-time polymerase chain reaction (PCR) in 628 CRC cases and 1,256 age and sex frequency matched cancer-free controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24498432'>24498432</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>This study suggested that short telomere length in PBLs was significantly associated with an increased risk of CRC in Chinese Han population.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24498432'>24498432</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Relative telomere length (RTL) of peripheral blood leukocytes (PBLs) from 571 CRC patients receiving surgical resection was measured using a polymerase chain reaction-based method.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24608194'>24608194</td>
<tr><td>Diabetes Mellitus, Periodontitis</td><td>Telomere Attrition</td><td>OBJECTIVE Shortened leukocyte telomere length (LTL) and diagnosis of periodontitis are associated with an increased risk of complications and mortality in diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24652728'>24652728</td>
<tr><td>Hypertensive (finding)</td><td>Telomere Attrition</td><td>Arterial mean telomere length was not different in hypertensive patients compared with nonhypertensive individuals (P = 0.29).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24686009'>24686009</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>Arterial mean telomere length was not associated with telomere uncapping or P53/P21-induced senescence (r = -0.02, P = 0.44 and r = 0.01, P = 0.50, respectively), but telomere uncapping was a highly influential covariate for the hypertension group difference in P53/P21-induced senescence (r = 0.62, P < 0.001, e(p)(2) = 0.35).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24686009'>24686009</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>Finally, telomere uncapping was a significant predictor of hypertension status (P = 0.03), whereas mean telomere length was not (P = 0.68).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24686009'>24686009</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>Collectively, these findings demonstrate that arterial telomere uncapping and P53/P21-induced senescence are linked to hypertension independently of mean telomere length, and telomere uncapping influences hypertension status more than mean telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24686009'>24686009</td>
<tr><td>disease stage</td><td>Telomere Attrition</td><td>We measured relative telomere length (RTL) and TERT expression levels in purified peripheral CD19(+) B-cells from seven healthy donors and 77 untreated CLLs in early stage disease (Binet A).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24706380'>24706380</td>
<tr><td>Metabolic Diseases</td><td>Telomere Attrition</td><td>Short telomere length, a marker of biological aging, has been associated with age-related metabolic disorders.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24799415'>24799415</td>
<tr><td>Toxicity aspects</td><td>Telomere Attrition</td><td>Telomere length (TL) and p53 mutation status were correlated with response and toxicity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24821881'>24821881</td>
<tr><td>Glioma</td><td>Telomere Attrition</td><td>1p34.2 rs621559 and 14q21 rs398652 leukocyte telomere length-related genetic variants contribute to glioma susceptibility.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24844311'>24844311</td>
<tr><td>Cocaine-Related Disorders, Diabetes Mellitus, Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Shorter leukocyte telomere length (LTL) has been associated with a wide range of age-related disorders including cardiovascular disease (CVD) and diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24861044'>24861044</td>
<tr><td>Depression, CTCAE, Diabetes Mellitus</td><td>Telomere Attrition</td><td>The goal of this study is to investigate the association between oxidative stress and telomere length shortening in the comorbid depression and diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24868316'>24868316</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24892036'>24892036</td>
<tr><td>Atherosclerosis, Carotid Atherosclerosis</td><td>Telomere Attrition</td><td>Short leukocyte telomere length (LTL) has been associated with atherosclerosis in cross-sectional studies, but the prospective relationship between telomere shortening and risk of developing carotid atherosclerosis has not been well-established.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/24902894'>24902894</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Therefore, we examined the relationships of plasma SDF-1 levels to cardiovascular disease (CVD)-related outcomes, risk factors, leukocyte telomere length, and endothelial progenitor cells.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25060794'>25060794</td>
<tr><td>Electrocardiogram: myocardial infarction (finding), Heart failure</td><td>Telomere Attrition</td><td>We used Cox regression to examine relationships of SDF-1 to new-onset CVD, myocardial infarction, heart failure, and all-cause mortality; we used linear regression to evaluate associations of SDF-1 with risk factors, leukocyte telomere length, and CD34+ cell phenotypes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25060794'>25060794</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Several studies have examined leukocyte telomere length (LTL) as a possible predictor for cancer at various organ sites.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25103821'>25103821</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Complete sequence analysis of mitochondrial DNA and telomere length in aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25119516'>25119516</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>The present study was primarily undertaken to examine the hypothesis that mitochondrial DNA (mtDNA) mutations and telomere length may be associated with aplastic anemia (AA).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25119516'>25119516</td>
<tr><td>Hematopoietic</td><td>Telomere Attrition</td><td>We conclude that the functional impairment of the mitochondrial respiratory chain induced by mutation and telomere length shortening may play an important role in the process of hematopoietic failure in patients with AA.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25119516'>25119516</td>
<tr><td>Hypertensive disease</td><td>Telomere Attrition</td><td>Multivariate analysis demonstrated that hypertension and telomere length were the only independent risk factors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25274533'>25274533</td>
<tr><td>Bone marrow hypocellularity</td><td>Telomere Attrition</td><td>Telomere length in inherited bone marrow failure syndromes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25304614'>25304614</td>
<tr><td>Shwachman syndrome, Dyskeratosis Congenita, Anemia, Diamond-Blackfan, Fanconi Anemia</td><td>Telomere Attrition</td><td>We compared telomere length in patients with Fanconi anemia, Diamond-Blackfan anemia and Shwachman-Diamond syndrome with telomere length in dyskeratosis congenita.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25304614'>25304614</td>
<tr><td>Sleep-Disordered Breathing, Sleep Apnea, CTCAE, daytime sleepiness</td><td>Telomere Attrition</td><td>Our investigation aims to assess the impact of symptoms of maternal sleep-disordered breathing, specifically sleep apnea risk and daytime sleepiness, on fetal leukocyte telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25325479'>25325479</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>We also measured relative telomere length (RTL) in tumors and difference between tumors with and without the TERT promoter mutations was not statistically significant.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25331263'>25331263</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Telomere length has a biological link to cancer, with excessive telomere shortening leading to genetic instability and resultant malignant transformation.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25351806'>25351806</td>
<tr><td>Lung Diseases, Interstitial</td><td>Telomere Attrition</td><td>Subclinical bone marrow and liver abnormalities can be seen in patients with ILD and short telomeres, in some cases in the absence of clinically significant abnormalities in peripheral blood counts and liver function tests.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25393420'>25393420</td>
<tr><td>Lung Diseases, Interstitial</td><td>Telomere Attrition</td><td>A larger study examining the implication of these findings on the outcome of patients with ILD and short telomeres is needed.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25393420'>25393420</td>
<tr><td>Progeria, Autosome</td><td>Telomere Attrition</td><td>We also find that lamin A/C interacts with TRF2 and that reduction in levels of lamin A/C or mutations in LMNA that cause an autosomal dominant premature ageing disorder--Hutchinson Gilford Progeria Syndrome (HGPS)-lead to reduced ITL formation and telomere loss.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25399868'>25399868</td>
<tr><td>Depression, CTCAE</td><td>Telomere Attrition</td><td>Kaplan-Meier plots and log-rank tests were used to compare survival time of subgroups by depression variables and telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25416716'>25416716</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>No significant difference in MDA concentration, telomere length and DNA damage was observed between groups, although longer telomere lengths were seen in the obese with diabetes group compared to the obese group (P<0.05).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25458337'>25458337</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>Lower MDA concentration and longer telomere length were seen in subjects with diabetes compared to those without (P<0.05).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25458337'>25458337</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Telomere length (TL) biomarker exploratory analysis was carried out in tumor tissue by quantitative PCR (qPCR) and telomerase fluorescence in situ hybridization.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25467017'>25467017</td>
<tr><td>Neoplasms, Stomach Neoplasms</td><td>Telomere Attrition</td><td>Telomere length of gastric tumors less than 2.86 kbp was a factor that led to a poor prognosis (relative risk = 4.420, with respect to tumors showing telomere length >= 2.86 kbp) (P = 0.002).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25486025'>25486025</td>
<tr><td>nervous system disorder</td><td>Telomere Attrition</td><td>Telomere shortening is related to premature cellular senescence and could be a marker for cellular pathology in neurological diseases.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25541866'>25541866</td>
<tr><td>Ataxia Telangiectasia, Presenile dementia, "Huntingtons Disease Pathway</td><td>Telomere Attrition</td><td>Relative telomere length in dementia (N=70), Huntingtons disease (N=35), ataxia telangiectasia (N=9), and age-group matched control samples (N=105) was measured as relative telomere copy/single copy gene ratios.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25541866'>25541866</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) and plasma homocysteine (HCY) have been independently associated with cardiovascular disease (CVD) morbidity and mortality.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25546508'>25546508</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>We find significantly shorter TL in subcutaneous compared to visceral AT (P < 0.001) which is consistent in men and subgroups of lean and obese, and individuals with or without type 2 diabetes (T2D).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25596130'>25596130</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25668263'>25668263</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>To evaluate the association between recipient and donor pretransplant leukocyte telomere length with outcomes after unrelated donor allogeneic hematopoietic cell transplantation (HCT) for patients with severe aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25668263'>25668263</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>Longer donor leukocyte telomere length was associated with higher survival probability (5-year overall survival, 56%; number at risk, 57; cumulative deaths, 50) than shorter donor leukocyte telomere length (5-year overall survival, 40%; number at risk, 71; cumulative deaths, 128; P = .009).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25668263'>25668263</td>
<tr><td>Graft-vs-Host Disease</td><td>Telomere Attrition</td><td>There was no association between donor telomere length and neutrophil engraftment at 28 days (cumulative incidence, 86% vs 85%; HR, 0.94; 95% CI, 0.73-1.22), acute graft-vs-host disease grades III-IV at 100 days (cumulative incidence, 22% vs 28%; HR, 0.77; 95% CI, 0.48-1.23), or chronic graft-vs-host disease at 1-year (cumulative incidence, 28% vs 30%; HR, 0.81; 95% CI, 0.53-1.24) for long vs short, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25668263'>25668263</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Longer donor leukocyte telomere length was associated with increased 5-year survival in patients who received HCT for severe aplastic anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25668263'>25668263</td>
<tr><td>Malignant Neoplasms, Glioma</td><td>Telomere Attrition</td><td>Epidemiological studies have demonstrated that leukocyte telomere length is associated with the developing risk of various malignancies, including glioma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25702101'>25702101</td>
<tr><td>Glioma</td><td>Telomere Attrition</td><td>Relative telomere length (RTL) of peripheral blood leukocytes from 301 glioma patients were examined using a real-time PCR-based method.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25702101'>25702101</td>
<tr><td>Unipolar Depression, Anxiety Disorders, Depressive disorder</td><td>Telomere Attrition</td><td>Significantly higher mtDNA copy numbers and shorter telomeres were seen in individuals with major depression, depressive disorders, and anxiety disorders, as well as those with parental loss and childhood maltreatment.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25749099'>25749099</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Tumors with TERT promoter mutations had shorter telomeres than those without.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25797251'>25797251</td>
<tr><td>Malignant Glioma</td><td>Telomere Attrition</td><td>TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25797251'>25797251</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>While our data affirm the role of TERT promoter mutations in glial tumors, effects on transcription and telomere length emphasise the importance of telomere biology in disease genesis and outcome.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25797251'>25797251</td>
<tr><td>Carcinoma of lung</td><td>Telomere Attrition</td><td>TLV and mean telomere length jointly affected lung cancer risk: when comparing individuals with short telomere length and high TLV to those with long telomere length and low TLV, adjusted odd ratios were 8.21 (95% CI: 1.71-39.5) and 0.33 (95% CI: 0.15-0.72) for younger and older individuals, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25840848'>25840848</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20</td><td>Telomere Attrition</td><td>Therefore, we examined the relationship between high dietary sodium intake and leukocyte telomere length (LTL), particularly in the context of obesity, as obesity increases salt sensitivity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25869605'>25869605</td>
<tr><td>Overweight</td><td>Telomere Attrition</td><td>Higher dietary sodium intake is associated with shorter telomere length in overweight and obese adolescents.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25869605'>25869605</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Specifically, molecular high-grade tumors were more frequent in patients with lower vitamin D levels whereas high immune tumors came from patients with predicted shorter telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/25871393'>25871393</td>
<tr><td>Stillbirth</td><td>Telomere Attrition</td><td>The objective of this study is to investigate placental telomere shortening in unexplained stillbirths (SBs) as an indication of premature senescence.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26004986'>26004986</td>
<tr><td>Preterm premature rupture of membranes (disorder)</td><td>Telomere Attrition</td><td>T/S was lower in SB compared with spontaneous preterm births (PTBs) (6.382 +- 5.525; p < 0.01), whereas SBs telomere length were similar to those of preterm premature rupture of membranes (pPROM) (3.296 +- 3.599; p = ns).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26004986'>26004986</td>
<tr><td>Chronic Lymphocytic Leukemia</td><td>Telomere Attrition</td><td>We have explored the relationship between telomere length (TL) and chromosome alterations studied by fluorescence in situ hybridization (FISH) and conventional cytogenetics in 107 newly diagnosed CLL patients; 61 normal controls were also evaluated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26008147'>26008147</td>
<tr><td>Gastro-enteropancreatic neuroendocrine tumor</td><td>Telomere Attrition</td><td>Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26026117'>26026117</td>
<tr><td>S100A4 protein, human</td><td>Telomere Attrition</td><td>Telomere length abnormalities are prevalent genetic alterations in malignant transformation.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26026117'>26026117</td>
<tr><td>ATRX gene, Mental Retardation, X-Linked, Cessation of life, Gastro-enteropancreatic neuroendocrine tumor</td><td>Telomere Attrition</td><td>We studied telomere length abnormalities, telomerase RNA component (TERC) expression, alpha-thalassemia X-linked mental retardation (ATRX) expression, and death domain-associated protein (DAXX) expression in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26026117'>26026117</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>We measured the relative telomere length (RTL) in cancerous tissues and in corresponding peripheral blood leukocytes (PBL) using quantitative PCR (Q-PCR) from 94 patients with CRC.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26047604'>26047604</td>
<tr><td>Age related macular degeneration</td><td>Telomere Attrition</td><td>To better understand how leukocyte telomere length (LTL) is related to AMD, we conducted an association study in 197 AMD patients and 259 healthy controls using the established quantitative PCR technique.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26049047'>26049047</td>
<tr><td>Neoplasms, Vascular Invasion Assessment, TNM Staging System</td><td>Telomere Attrition</td><td>Mean telomere length was significantly less in patients with TNM stage III, and in those with large tumors, lymph node metastases and vascular invasion.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26080929'>26080929</td>
<tr><td>ETV3 wt Allele</td><td>Telomere Attrition</td><td>We examined whether baseline MetS components predict TL over time, and whether deteriorations in MetS parallel telomere attrition.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26133009'>26133009</td>
<tr><td>Sarcoma</td><td>Telomere Attrition</td><td>The difference in telomere length was statistically significant in the two types of sarcomas (P=0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26191279'>26191279</td>
<tr><td>Endocrine System Diseases</td><td>Telomere Attrition</td><td>To examine specifically whether cellular ageing, as measured by leukocyte telomere length (LTL), is correlated with the presence of endocrine disturbance.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26300027'>26300027</td>
<tr><td>Carotid Intima-Media Thickness</td><td>Telomere Attrition</td><td>Male sex, younger paternal age and higher maternal body mass index were associated with shorter telomere length in early childhood, which in turn was associated with greater carotid intima-media thickness at age 8 years (standardised b = -0.159, P = 0.01).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26405259'>26405259</td>
<tr><td>Pituitary Adenoma, Acromegaly</td><td>Telomere Attrition</td><td>Patients with acromegaly exhibited shorter telomere length than age-, sex-, smoking-, and diabetes-matched control patients with non-functioning pituitary adenoma (0.62 +- 0.23 vs. 0.75 +- 0.35, respectively, P = 0.047).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26448623'>26448623</td>
<tr><td>Glioma</td><td>Telomere Attrition</td><td>TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26556853'>26556853</td>
<tr><td>Glioma</td><td>Telomere Attrition</td><td>To investigate the prognostic value of these mutations and telomere length, individually and their coexistence, in gliomas, we analyzed two somatic mutations C228T and C250T in the TERT promoter, relative telomere length (RTL), IDH1 mutation and MGMT methylation in 389 glioma patients, and explored their associations with patient characteristics and clinical outcomes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26556853'>26556853</td>
<tr><td>Squamous cell carcinoma of esophagus, Extrapulmonary Small Cell Carcinoma, Malignant Neoplasms</td><td>Telomere Attrition</td><td>Epidemiological studies have suggested that inter-individual differences of telomere length could affect predisposition to multiple cancers, but evidence regarding esophageal squamous cell carcinoma (ESCC) was still uncertain.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26581417'>26581417</td>
<tr><td>Adenocarcinoma, EGFR Positive, Squamous cell carcinoma</td><td>Telomere Attrition</td><td>3D telomeric profiling demonstrated that the smokers, EGFR-negative, and squamous cell carcinoma subgroups tended to have higher numbers of lower-intensity telomeres, indicative of shorter telomeres, as well as higher numbers of telomeric aggregations compared to non-smokers, EGFR-positive, and adenocarcinomas, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26621152'>26621152</td>
<tr><td>Inflammation</td><td>Telomere Attrition</td><td>Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26629551'>26629551</td>
<tr><td>Primary malignant neoplasm, Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL), a reliable biomarker of genomic instability, is associated with increased risk of cancer and cardiovascular disease.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26655528'>26655528</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Short leucocyte telomere length (LTL) might be a risk factor for cardiovascular diseases (CVD).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26666879'>26666879</td>
<tr><td>Rheumatoid Arthritis</td><td>Telomere Attrition</td><td>A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26773113'>26773113</td>
<tr><td>Atrial Fibrillation, Cerebrovascular accident, Cardioembolic stroke</td><td>Telomere Attrition</td><td>The peripheral blood leukocyte telomere length (LTL) was determined by real-time polymerase chain reaction in 187 patients with AF, 93 of them without stroke history and 94 of them having suffered 1 cardioembolic stroke.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26786116'>26786116</td>
<tr><td>Gallbladder Carcinoma, Cholelithiasis</td><td>Telomere Attrition</td><td>Here, we evaluated the influence of subtelomeric methylation in telomere dysfunction in gallbladder cancer (GBC), and whether this dysfunction is affected by the presence of gallstones.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26856965'>26856965</td>
<tr><td>Cholelithiasis</td><td>Telomere Attrition</td><td>Relative telomere length and subtelomeric methylation levels were assessed using monochrome multiplex quantitative polymerase chain reaction and bisulfite sequencing, respectively, in different gallbladder tissue types including different grades of GBC, gallstones and adjacent non-tumor.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26856965'>26856965</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>We found telomere length to shorten significantly in overall GBC, but specifically in early grade cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26856965'>26856965</td>
<tr><td>Cholelithiasis</td><td>Telomere Attrition</td><td>Interestingly, telomere length and subtelomeric methylation differed significantly in GBC without gallstones but not in GBC with gallstones.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26856965'>26856965</td>
<tr><td>Tumor-Infiltrating Immune Cell, Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26883253'>26883253</td>
<tr><td>Colorectal Carcinoma, Malignant Neoplasms</td><td>Telomere Attrition</td><td>A large number of studies have investigated leukocyte telomere length as a possible risk marker for various cancers, colorectal cancer (CRC) included.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26883253'>26883253</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>In contrast, studies investigating leukocyte telomere length in relation to CRC survival are lacking.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26883253'>26883253</td>
<tr><td>CXCL14 gene</td><td>Telomere Attrition</td><td>We previously reported that relative telomere length (RTL) of leukocytes collected at diagnosis predicted survival in patients with breast and kidney cancer.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26883253'>26883253</td>
<tr><td>Disability</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) is known to be associated with mortality, but its association with age-related decline in physical functioning and the development of disability is less clear.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/26940017'>26940017</td>
<tr><td>Adult Non-Hodgkin Lymphoma, Lymphoma, Non-Hodgkin, Familial</td><td>Telomere Attrition</td><td>Evidence from a small number of studies suggests that longer telomere length measured in peripheral leukocytes is associated with an increased risk of non-Hodgkin lymphoma (NHL).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27008888'>27008888</td>
<tr><td>Lymphoma, Non-Hodgkin, Familial</td><td>Telomere Attrition</td><td>However, these studies may be biased by reverse causation, confounded by unmeasured environmental exposures and might miss time points for which prospective telomere measurement would best reveal a relationship between telomere length and NHL risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27008888'>27008888</td>
<tr><td>Lymphoma, Non-Hodgkin, Familial</td><td>Telomere Attrition</td><td>We performed an analysis of genetically inferred telomere length and NHL risk in a study of 10 102 NHL cases of the four most common B-cell histologic types and 9562 controls using a genetic risk score (GRS) comprising nine telomere length-associated single-nucleotide polymorphisms.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27008888'>27008888</td>
<tr><td>Lymphoma, Non-Hodgkin, Familial</td><td>Telomere Attrition</td><td>The analysis of the telomere length GRS resulted in an association between longer telomere length and increased NHL risk [four B-cell histologic types combined; odds ratio (OR) = 1.49, 95% CI 1.22-1.82,P-value = 8.5 x 10(-5)].</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27008888'>27008888</td>
<tr><td>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin, Familial</td><td>Telomere Attrition</td><td>Our results indicate that a genetic background that favors longer telomere length may increase NHL risk, particularly risk of CLL/SLL, and are consistent with earlier studies relating longer telomere length with increased NHL risk.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27008888'>27008888</td>
<tr><td>Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>Individuals with type 2 diabetes show shorter leukocyte telomere length (LTL) compared to people without diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27020053'>27020053</td>
<tr><td>Hereditary Melanoma, melanoma</td><td>Telomere Attrition</td><td>Patients with sporadic melanoma were found to have shorter telomeres compared with those with familial melanoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27061190'>27061190</td>
<tr><td>melanoma</td><td>Telomere Attrition</td><td>Differences in telomere length between sporadic and familial cutaneous melanoma.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27061190'>27061190</td>
<tr><td>Tumor necrosis</td><td>Telomere Attrition</td><td>Blood samples were collected to measure leukocyte telomere length (LTL), levels of interleukin-6 (IL-6) and other circulating markers potentially informative for aging and frailty: Interleukin-10 (IL-10), Tumor Necrosis Factor Alpha (TNF-a), Insulin-like Growth Factor 1 (IGF-1), Monocyte Chemotactic Protein 1 (MCP-1) and Regulated on Activation, Normal T cell Expressed and Secreted (RANTES).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27102154'>27102154</td>
<tr><td>Myocardial Ischemia, Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>To explore the association between plasma antioxidant status, marker of cellular ageing (leukocyte telomere length, LTL) and 10years risk of IHD in patients with T2D.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27156058'>27156058</td>
<tr><td>South Dakota, Plaque -- tissue</td><td>Telomere Attrition</td><td>One SD increase in relative telomere length was associated with carotid plaque (OR (95% CI)=1.65 (0.99-2.75) (p=0.05)) and vascular cell adhesion molecule-1 concentrations (b (SE)=-0.05031 (0.02480) (p=0.04)) in black and white patients, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27157144'>27157144</td>
<tr><td>BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20</td><td>Telomere Attrition</td><td>Telomeres may be considered markers of biological aging, shorter telomere length is associated with some age-related diseases; in several studies short telomere length has also been associated to obesity in adults and adolescents.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27157420'>27157420</td>
<tr><td>Sleep Disorders</td><td>Telomere Attrition</td><td>Sleep disorders may lead to stress-induced premature aging and telomere shortening.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27163410'>27163410</td>
<tr><td>Adenoma</td><td>Telomere Attrition</td><td>Here, we measured relative telomere length (RTL) by real-time quantitative PCR in 90 adenomas (aRTL), 419 stage I-IV CRCs (cRTL) and adjacent normal mucosa (nRTL).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27167335'>27167335</td>
<tr><td>CTC1 gene, Chronic Lymphocytic Leukemia</td><td>Telomere Attrition</td><td>In ancestry-adjusted case-control comparisons, we analyzed eight SNPs in genes definitively associated with inter-individual variation in leukocyte telomere length (LTL) in prior genome-wide association studies: ACYP2, TERC, NAF1, TERT, OBFC1, CTC1, ZNF208, and RTEL1 RESULTS: Three of the eight LTL-associated SNPs were associated with CLL risk at P < 0.05, including those near: TERC [OR, 1.46; 95% confidence interval (CI), 1.15-1.86; P = 1.8 x 10(-3)], TERT (OR = 1.23; 95% CI, 1.02-1.48; P = 0.030), and OBFC1 (OR, 1.36; 95% CI, 1.08-1.71; P = 9.6 x 10(-3)).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27197291'>27197291</td>
<tr><td>Childhood Leukemia</td><td>Telomere Attrition</td><td>Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Childrens Oncology Group.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27354474'>27354474</td>
<tr><td>Leukopenia, Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>Our objective was to evaluate the impact of telomere length on duration of post-therapy neutropenia in a pediatric AML cohort.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27354474'>27354474</td>
<tr><td>alpha 1-Antitrypsin Deficiency</td><td>Telomere Attrition</td><td>This study aimed to assess telomere length in AATD patients and to study its association with a1-antitrypsin phenotypes.Telomere length, telomerase activity, telomerase reverse transcriptase (hTERT) expression and biomarkers of oxidative stress were measured in 62 children and teenagers (aged 2-18 years) diagnosed with AATD and 18 controls (aged 3-16 years).Our results show that intermediate-risk (MZ; SZ) and high-risk (ZZ) AATD patients have significantly shorter telomeres and increased oxidative stress than controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27390278'>27390278</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>Leukocyte telomere length and mortality risk in patients with type 2 diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27437767'>27437767</td>
<tr><td>Diabetes Mellitus, Non-Insulin-Dependent</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) shortening is found in a number of age-related diseases, including type 2 diabetes (T2DM).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27437767'>27437767</td>
<tr><td>Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Telomere erosion can lead to genomic instability and cancer progression.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27465399'>27465399</td>
<tr><td>PAFAH1B1 wt Allele, NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology</td><td>Telomere Attrition</td><td>Some studies have shown shorter TL in myelodysplastic syndrome (MDS) patients but the critically short telomeres, the variability of TL within individual patient has not been evaluated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27465399'>27465399</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>MDS patients showed eroded telomeres and narrow distribution compared to the NC (P < 0.001, P = 0.018, respectively).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27465399'>27465399</td>
<tr><td>NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology</td><td>Telomere Attrition</td><td>Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27465399'>27465399</td>
<tr><td>Liver carcinoma</td><td>Telomere Attrition</td><td>Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27558242'>27558242</td>
<tr><td>Malignant Neoplasms</td><td>Telomere Attrition</td><td>Increasing evidence suggests that alterations in mitochondrial DNA (mtDNA) copy number (mtDNAcn) and relative telomere length (RTL) may be implicated in the tumorigenesis of several malignancies.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27558242'>27558242</td>
<tr><td>Acute Promyelocytic Leukemia</td><td>Telomere Attrition</td><td>Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27632567'>27632567</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27641680'>27641680</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>We previously showed an association between donor leukocyte relative telomere length (RTL) and post-hematopoietic cell transplantation (HCT) survival in patients with severe aplastic anemia (SAA) who received bone marrow grafts at ages <40 years.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27641680'>27641680</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Telomere length, a marker of biological aging, has been associated with cardiovascular disease (CVD) and its risk factors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27660162'>27660162</td>
<tr><td>Inflammation</td><td>Telomere Attrition</td><td>Finally, we end on an optimistic note by demonstrating that family-centered prevention programs can have health benefits by reducing inflammation, helping to preserve telomere length, and inhibiting epigenetic aging.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27692007'>27692007</td>
<tr><td>Pregnancy Complications</td><td>Telomere Attrition</td><td>Independent of maternal and paternal age at birth, maternal education, gestational age, newborn gender, ethnicity, birthweight, maternal smoking status, parity, cesarean section, and pregnancy complications, each kg/m2 increase in pre-pregnancy BMI was associated with a -0.50 % (95 % CI, -0.83 to -0.17 %; P = 0.003) shorter cord blood telomere length and a -0.66 % (95 % CI, -1.06 to -0.25 %; P = 0.002) shorter placental telomere length.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27751173'>27751173</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27783614'>27783614</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>Short telomere length independently predicts mortality in patients with coronary heart disease.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27783614'>27783614</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>Whether 5-year change in telomere length predicts subsequent mortality in patients with coronary heart disease has not been evaluated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27783614'>27783614</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>In a prospective cohort study of 608 individuals with stable coronary artery disease, we measured leukocyte telomere length at baseline and after five years of follow-up.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27783614'>27783614</td>
<tr><td>Coronary Artery Disease</td><td>Telomere Attrition</td><td>In patients with coronary heart disease, an increase in leukocyte telomere length over 5 years is associated with decreased mortality.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27783614'>27783614</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Leukocyte telomere length (LTL) is a putative biological marker of immune system age, and there are demonstrated associations between LTL and cardiovascular disease.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27898678'>27898678</td>
<tr><td>Coronary Artery Disease, Cardiomyopathy, Dilated</td><td>Telomere Attrition</td><td>Patients with coronary artery disease survived for a shorter time and also had shorter LTL (both P < 0.05 after adjustment for age and sex) than subjects with dilated cardiomyopathy.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27978413'>27978413</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>Patients with non-cardiac causes of death had shorter LTL than patients with cardiac causes (P < 0.05 after adjustment for age).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27978413'>27978413</td>
<tr><td>Cessation of life</td><td>Telomere Attrition</td><td>However, shorter LTL was a marker of non-cardiac causes of death.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27978413'>27978413</td>
<tr><td>Cartilage-hair hypoplasia</td><td>Telomere Attrition</td><td>In particular children (<18 years) with CHH had shorter telomeres than controls (median RTL 1.12 vs 1.26, p=0.008).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27986801'>27986801</td>
<tr><td>Cartilage-hair hypoplasia</td><td>Telomere Attrition</td><td>We measured relative telomere length (RTL) in patients with CHH, their first-degree relatives and healthy controls and correlated RTL with clinical and laboratory features.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/27986801'>27986801</td>
<tr><td>Non-alcoholic Fatty Liver Disease</td><td>Telomere Attrition</td><td>Shorter telomere length and increased cellular senescence was demonstrated in patients with NAFLD, compared to the CC patients and healthy controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28006764'>28006764</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>This study aimed to synthesize the evidence on the association between peripheral blood leucocytes (PBL) telomere length and the risk of colorectal cancer (CRC).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28056862'>28056862</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Future well powered, large prospective studies on the relationship between telomere length and the risk of CRC, and the investigations of the biologic mechanisms are recommended.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28056862'>28056862</td>
<tr><td>NUMBL gene</td><td>Telomere Attrition</td><td>The HR NBL survivors had significantly shorter telomere length and higher serum levels of high sensitivity C-reactive protein than did the controls.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28067869'>28067869</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>Promoter mutations in telomerase reverse transcriptase (TERT) and telomere length have been studied in various tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28151853'>28151853</td>
<tr><td>Neoplasms, FAM126A gene</td><td>Telomere Attrition</td><td>TERT promoter mutation and telomere length were analyzed in 162 tumor samples of the patients with HCC by sequencing and real-time PCR, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28151853'>28151853</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>The telomere length was not significantly different in the presence of a TERT promoter mutation but was shorter in high-grade tumor stages (P = 0.048).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28151853'>28151853</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>The associations between individual cardiovascular disease risk factors and leukocyte telomere length (LTL) have been inconclusive.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28154163'>28154163</td>
<tr><td>Malignant neoplasm of ovary, Primary malignant neoplasm</td><td>Telomere Attrition</td><td>Background: The associations between telomere length and cancer risk are equivocal, and none have examined the association between prediagnosis leukocyte telomere length (LTL) and the risk of developing ovarian cancer.Methods: We prospectively measured LTL collected from 442 ovarian cancer cases and 727 controls in the Nurses Health Studies and the Northern Sweden Health and Disease Study.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28209595'>28209595</td>
<tr><td>Neoplasms</td><td>Telomere Attrition</td><td>In this study, leukocyte telomere length was investigated both as a risk marker, comparing control subjects and patient risk groups (based on serum levels of prostate-specific antigen, tumor differentiation, and tumor stage), and as a prognostic marker for metastasis-free and cancer-specific survival.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28222672'>28222672</td>
<tr><td>Hematopoietic Neoplasms, Myeloid neoplasm</td><td>Telomere Attrition</td><td>Telomere shortening is thought to be involved in the pathophysiology of myeloid malignancies, but telomere lengths (TL) during interphase and metaphase in hematopoietic malignancies have not been analyzed.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28224765'>28224765</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>A retrospective cross-sectional population was obtained from the CSU Diabetes Screening Research Initiative database where 273 participants had both ECG-derived QRS duration and DNA to permit leukocyte telomere length (LTL) determination.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28249683'>28249683</td>
<tr><td>Diabetes Mellitus</td><td>Telomere Attrition</td><td>Impact statement * Contradictory epidemiologic data have been obtained about the link between the leucocyte telomere length (LTL) and diabetes.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28299976'>28299976</td>
<tr><td>Cardiovascular Diseases, Disease, Physiologic calcification, Haploinsufficiency</td><td>Telomere Attrition</td><td>Here, we demonstrate that telomere shortening in NOTCH1-haploinsufficient mice is sufficient to elicit age-dependent cardiovascular disease involving premature calcification of the aortic valve, a phenotype that closely mimics human disease caused by NOTCH1 haploinsufficiency.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28346225'>28346225</td>
<tr><td>Cardiovascular Diseases</td><td>Telomere Attrition</td><td>Methods We measured leukocyte telomere length (LTL) and plasma PAI-1 in 2560 American Indians who were free of overt cardiovascular disease (CVD) and participated in the Strong Heart Family Study (SHFS) clinical examination in 2001-2003.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28378522'>28378522</td>
<tr><td>HIV Infections</td><td>Telomere Attrition</td><td>In the multivariate analysis, significant predictors of shorter telomere length were older age (P = 0.008), parental age at birth (P = 0.038), white race (P = 0.048), and longer time of known HIV infection (10-20 and >=20 years compared with <10 years, P = 0.003 and P = 0.056, respectively).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28418989'>28418989</td>
<tr><td>Inflammation</td><td>Telomere Attrition</td><td>While BM-MNC telomere attrition was not related with alterations in TERT, TRF1/2 and Sirt1 expression, IFNy levels were associated with p21Cip1/p16lnk4A upregulation, suggesting a link between inflammation and cellular senescence.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28434530'>28434530</td>
<tr><td>Impaired T cell function, Myocardial Ischemia, Myeloid Cell Differentiation</td><td>Telomere Attrition</td><td>This telomere shortening was associated with reduced myeloid differentiation capacity of BM-MNC, suggesting accelerated senescence as underlying cause for progenitor cell dysfunction in IHD.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28434530'>28434530</td>
<tr><td>Myocardial Ischemia</td><td>Telomere Attrition</td><td>Still, the trigger for telomere shortening in IHD needs to be elucidated.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28434530'>28434530</td>
<tr><td>Coronary Artery Disease, Heart failure</td><td>Telomere Attrition</td><td>We analysed telomere length of BM-derived mononuclear cells (MNC) by MMqPCR in patients with coronary artery disease (n = 12), ischemic heart failure (HF; n = 9), non-ischemic HF (n = 7) and controls (n = 10), and related it to their myeloid differentiation capacity.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28434530'>28434530</td>
<tr><td>Cardiomyopathies, Myocardial Ischemia</td><td>Telomere Attrition</td><td>BM-MNC telomere length was shortened in patients with IHD, irrespective of associated cardiomyopathy, and shortened further with increasing angiographic lesions.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28434530'>28434530</td>
<tr><td>Acute myocardial infarction</td><td>Telomere Attrition</td><td>Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28444175'>28444175</td>
<tr><td>PAFAH1B1 wt Allele</td><td>Telomere Attrition</td><td>Therefore, telomere length should be assessed in a larger prospective study to confirm its prognostic role in MDS with a view to integrating this variable into a revised IPSS.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28486748'>28486748</td>
<tr><td>Mental disorders</td><td>Telomere Attrition</td><td>Positive association between telomere length and mitochondrial DNA (mtDNA) copy number were introduced in healthy and patients with psychiatric disorder.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28488129'>28488129</td>
<tr><td>Serrated intestinal polyps, Colorectal Tubular Adenoma</td><td>Telomere Attrition</td><td>DNA was extracted from 109 CRCs, 64 colorectal tubular adenomas (TAs), and 28 serrated polyps (SPs), and then, telomere length and mtDNA copy number were analyzed in these legions by using a real-time PCR assay.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28488129'>28488129</td>
<tr><td>Colorectal Carcinoma</td><td>Telomere Attrition</td><td>Telomere length and mtDNA copy number did not show clinical and prognostic values in CRCs, however, positive correlation between telomere length and mitochondrial DNA copy number were found in CRC (r = 0.408, p < 0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28488129'>28488129</td>
<tr><td>Chronic heart failure</td><td>Telomere Attrition</td><td>The effect of CD34+ cell telomere length and hTERT expression on the outcome of autologous CD34+ cell transplantation in patients with chronic heart failure.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28636901'>28636901</td>
<tr><td>Cardiomyopathies</td><td>Telomere Attrition</td><td>Our findings demonstrate that CD34+ cell telomere length may not influence the clinical outcome in cardiomyopathy patients treated with autologous CD34+ cell transplantation.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28636901'>28636901</td>
<tr><td>Fibrosis Assessment, Extrinsic allergic alveolitis</td><td>Telomere Attrition</td><td>In the combined UCSF and UTSW chronic hypersensitivity pneumonitis cohort, we saw associations between extent of radiographic fibrosis and MUC5B rs35705950 minor alleles (adjusted odds ratio [OR] 1*91, 95% CI 1*02-3*59, p=0*045) and short telomere length (adjusted OR per unit change in mean natural logarithm-transformed ratio of telomere repeat copy number to single gene copy number 0*23, 0*09-0*59, p=0*002).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28648751'>28648751</td>
<tr><td>Leukemia, Myelocytic, Acute</td><td>Telomere Attrition</td><td>We estimate patients harboring approximately 20 years of premature telomere loss compared to healthy aged-matched subjects at the time of AML onset.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28674830'>28674830</td>
<tr><td>Liver Cirrhosis</td><td>Telomere Attrition</td><td>We found that telomere length was reduced in individuals with NAFLD-HCC versus those with cirrhosis (P = 0.048) and healthy controls (P = 0.0006), independently of age and sex.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28677271'>28677271</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28699658'>28699658</td>
<tr><td>CDISC SDTM Immunogenicity Specimen Assessments Test Name Terminology</td><td>Telomere Attrition</td><td>Shorter TL can be used not only as a biomarker, but also as a predictive marker for treatment response to IST.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28699658'>28699658</td>
<tr><td>Neoplasms, VHL protein, human</td><td>Telomere Attrition</td><td>These results indicate that blood shorter telomere length is a new biomarker for age-related tumor risks in VHL patients, which will be crucial to genetic counseling and future research about the role of telomere shortening in the pathogenesis of VHL-associated tumors.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28776935'>28776935</td>
<tr><td>Neoplasms, Von Hippel-Lindau Syndrome</td><td>Telomere Attrition</td><td>Shorter telomere length increases age-related tumor risks in von Hippel-Lindau disease patients.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28776935'>28776935</td>
<tr><td>Neoplasms, VHL protein, human</td><td>Telomere Attrition</td><td>VHL patients showed significantly shorter telomere length than healthy family controls(P = 0.0183), and a positive correlation was found between telomere length and onset age of the five major tumors, respectively.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28776935'>28776935</td>
<tr><td>Neuroendocrine Tumors, Pancreatic Cyst, Hemangioblastoma, Renal Cell Carcinoma</td><td>Telomere Attrition</td><td>Moreover, patients in the shorter telomere group (age-adjusted telomere length <= 0.44) suffered higher age-related risks for VHL-associated central nervous system hemangioblastomas (HR: 1.879, P = 0.004), renal cell carcinoma (HR: 2.126, P = 0.002) and pancreatic cyst and neuroendocrine tumors (HR: 2.093, P = 0.001).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28776935'>28776935</td>
<tr><td>Liver Cirrhosis, FAM126A gene</td><td>Telomere Attrition</td><td>Telomere length of peripheral blood leukocytes was measured by Southern blot and qPCR in 120 patients with HCC associated with cirrhosis and 261 healthy subjects.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28813500'>28813500</td>
<tr><td>Premature Obstetric Labor, Labor (Childbirth), Neoplasms, Chorioamnionitis</td><td>Telomere Attrition</td><td>In the chorioamniotic membranes without acute histologic chorioamnionitis: (1) the expression profile of senescence-associated genes was different between the labor groups (term in labor and preterm in labor) and the nonlabor groups (term no labor and preterm no labor), yet there were differences between the term in labor and preterm in labor groups; (2) most of the differentially expressed genes among the groups were closely related to the tumor suppressor protein (TP53) pathway; (3) the expression of TP53 was down-regulated in the term in labor and preterm in labor groups compared to their nonlabor counterparts; (4) the expression of CDKN1A (gene coding for p21) was up-regulated in the term in labor and preterm in labor groups compared to their nonlabor counterparts; (5) the expression of the cyclin kinase CDK2 and cyclins CCNA2, CCNB1, and CCNE1 was down-regulated in the preterm in labor group compared to the preterm no labor group; (6) the concentration of TP53 was lower in the preterm in labor group than in the preterm no labor and term in labor groups; (7) the senescence-associated b-galactosidase activity was greater in the preterm in labor group than in the preterm no labor and term in labor groups; (8) the concentration of phospho-S6 ribosomal protein was reduced in the term in labor group compared to its nonlabor counterpart, but no differences were observed between the preterm in labor and preterm no labor groups; and (9) no significant differences were observed in relative telomere length among the study groups (term no labor, term in labor, preterm no labor, and preterm in labor).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28847437'>28847437</td>
<tr><td>Aplastic Anemia</td><td>Telomere Attrition</td><td>A bone marrow aspirate showed marked hypocellularity consistent with severe aplastic anemia, and telomere testing revealed very short telomeres.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28866069'>28866069</td>
<tr><td>Premature coronary artery atherosclerosis</td><td>Telomere Attrition</td><td>Association Between Oxidative Stress and Peripheral Leukocyte Telomere Length in Patients with Premature Coronary Artery Disease.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28892468'>28892468</td>
<tr><td>Schizophrenia</td><td>Telomere Attrition</td><td>A significant reduction in telomere length was observed in STG white matter of patients with schizophrenia as compared to controls (fold change of -0.42, U = 5, P = 0.008).</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28910708'>28910708</td>
<tr><td>BONE MARROW FAILURE SYNDROME 1, Dyskeratosis Congenita</td><td>Telomere Attrition</td><td>Dyskeratosis congenita (DC) is a rare, inherited, bone marrow failure syndrome caused by premature telomere shortening.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28923296'>28923296</td>
<tr><td>herpesvirus 1, human</td><td>Telomere Attrition</td><td>This study examined the association of 4 human herpesviruses (CMV, herpes simplex virus type 1, human herpesvirus type 6, and Epstein-Barr virus) with change in leukocyte telomere length (LTL) over 3 years in 400 healthy individuals (aged 53-76 years) from the Whitehall II cohort.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28931225'>28931225</td>
<tr><td>Left Ventricular Hypertrophy, Atherosclerosis, Cardiovascular Diseases</td><td>Telomere Attrition</td><td>In European descent populations, shorter leukocyte telomere length (LTL) has been associated with subclinical atherosclerosis, cardiovascular disease (CVD), and mortality, while longer LTL has been associated with greater left ventricular hypertrophy.</td><td><a href='https://pubmed.ncbi.nlm.nih.gov/28950166'>28950166</td>
</table>
</div>
<script>
  // Script for table from https://www.w3schools.com.

function myFunction() {
  var input, filter, table, tr, td, i, txtValue;
  input = document.getElementById("myInput");
  filter = input.value.toUpperCase();
  table = document.getElementById("myTable");
  tr = table.getElementsByTagName("tr");
  for (i = 0; i < tr.length; i++) {
    td = tr[i].getElementsByTagName("td")[0];
    if (td) {
      txtValue = td.textContent || td.innerText;
      if (txtValue.toUpperCase().indexOf(filter) > -1) {
        tr[i].style.display = "";
      } else {
        tr[i].style.display = "none";
      }
    }       
  }
}
</script>
</div>
</body>
</html>

